American College of Clinical Pharmacy
      Search      Cart
         
PRN Report
 Prev
Next 

PRN News Briefs

Adult Medicine PRN

Promotions

  • Nicole Campbell: Clinical Associate Professor of Pharmacy Practice, Fairleigh Dickinson University SoPHS.
  • Kristina Evans: Residency Program Director, PGY2 Internal Medicine Program, Grady Health System, Atlanta, GA.
  • Julie Murphy: Professor, The University of Toledo.
  • Heather Savage: Residency Program Director, Ochsner Medical Center.
  • Taylor Steuber: Clinical Professor, University of Missouri, Kansas City.
  • Andrew Stone: Senior Clinical Pharmacy Specialist, The Ohio State University Wexner Medical Center.
  • Huyentran Tran: Professor, Loma Linda University.

Awards

  • Heather Savage: Pharmacist of the Year, Louisiana Society of Health-System Pharmacists.
  • Mate Soric: Class of 2026 Commencement Hooder, Northeast Ohio Medical University.
  • Andrew Stone: Preceptor of the Year, The Ohio State University College of Pharmacy Class of 2026.
  • Alexandra Tatara: Most Influential Preceptor, The University of Texas Southwestern Medical Center PGY1 Pharmacy Residency Program.
  • Jon P. Wietholter: 2026 Outstanding Program Award (Established Program), WVU School of Pharmacy & University of Western Cape Collaboration, American Association of Colleges of Pharmacy (AACP) Global Education SIG.

Publications

  • Landup D, Dunn EH, Van Dril E, et al. The cost conundrum: pharmacists at the crossroads of evidence and affordability. J Am Coll Clin Pharm. 2026;9(2):e70181. https://doi.org/10.1002/jac5.70181
  • Falahat S, Das J, Bhaumik D, et al. Bridging technology and education: the use of ChatGPT in grading pharmacy student exams. Curr Pharm Teach Learn. 2026;18(10):102707. http://doi.org/10.1016/j.cptl.2026.102707
  • Cheng Y, Gaborcik JW, Smith RM, Dungan K, Stone AC. Insulin glargine use in dexamethasone-induced hyperglycemia: a retrospective cohort analysis. Ann Pharmacother. 2026 Jul 8. [Epub ahead of print]. https://doi.org/10.1177/10600280261457153
  • Gibson CM, Escaño AK, Hobe KD, et al. Safety and effectiveness of somatostatin and analogues on chest tube output after coronary artery bypass grafting: a scoping review. J Cardiovasc Pharmacol. 2026;88(2):155-160. https://doi.org/10.1097/FJC.0000000000001810
  • DiVall MV, Dey S, Dang D, Gibson CM, et al. Flexible work arrangements in pharmacy academia: an overdue imperative. Am J Pharm Educ. 2026;90(9):102039. https://doi.org/10.1016/j.ajpe.2026.102039
  • O’Connell MB, Prescott GM, Allen M, Connor SE, Ford E, Formea CM, Gibson CM, et al. ACCP White Paper: From awareness to action: increasing health equity by addressing cultural and structural barriers in pharmacy practice, education, and research. J Am Coll Clin Pharm. 2026;9(4):e70206. https://doi.org/10.1002/jac5.70206
  • Zhang B, Bridgeman M, Gonzalez J. Mind the (scholarship) gap: strategies for cultivating the next generation of clinician-scientists. Curr Pharm Teach Learn. 2026;18(9):102687. https://doi.org/10.1016/j.cptl.2026.102687
  • Van TL, Hanners EK, Soni HP, et al. Impact of an in-house resident clinical pharmacist on-call program on resident physician training: a cross-sectional survey. J Am Coll Clin Pharm. 2026;9(3):e70191. https://doi.org/10.1002/jac5.70191
  • McGiness TM, Finch C. Asthma and chronic obstructive pulmonary disease. In: Franks A, Marrs J, Parker RB, et al, eds. The APhA Complete Review for Pharmacy. 14th ed. American Pharmacists Association; 2026.
  • Mersfelder T. Saint Raphael and the Patron Saints of Pharmacy. The Catholic Treehouse; 2026.
  • Metzger NL, Adams KK, Khoury A, Kinney EM. Comment on “Adopting race-free estimated glomerular filtration rate for unifying medication-related decision-making: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy.” J Am Coll Clin Pharm. 2026;9(4):e70207. https://doi.org/10.1002/jac5.70207
  • Billington ME, Metzger NL. Could anti-Xa monitoring prevent clots in ICU patients? NEJM Clin. 2026 June 12.
  • Mihm AE, Wingler AJ, Owen MP, et al. Evaluation of inhaler prescribing trends in hospitalized patients with suspected but unconfirmed chronic obstructive pulmonary disease. J Pharm Technol. 2026 Jun 29. [Epub ahead of print]. https://doi.org/10.1177/87551225261454868
  • Murphy JA, Maktabi L, Matus C. Anticonvulsants. In: Reinert JP, Branam DL, Veronin MA, et al, eds. Adjunctive Analgesic Strategies for the Bedside Clinician and Beyond: An Interdisciplinary Approach to Pain Management. Springer Nature; 2026.
  • Walter J, Bateman MT, Giaquinto A, Greer D, Liu M, Mansukhani R, O’Kane C, et al. A survey exploring perceptions and influences of professional dress in the profession of pharmacy. Pharm Educ. 2026;26(1):255-268. https://doi.org/10.46542/pe.2026.261.255268
  • Skory B, Arko J, Terkawi L, Slusarz E, King O, Deokarran C, Glista K, Will M, Etemadi H, Brosch E, Wasowski E, Soric MM. Prevalence of beta blocker prescribing for hypertension. J Pharm Technol. 2026;42(3):115-122. https://doi.org/10.1177/87551225261417534
  • Steuber TD, Belk M, Thayer B, et al. Nirmatrelvir-ritonavir versus short-course remdesivir for mild COVID-19 in high-risk hospitalized patients: a propensity score-matched study. J Pharm Technol. 2026;42(4):181-186. https://doi.org/10.1177/87551225261436716
  • Steuber CO, Bowers BL, Englin EF, Moreno NM, Campbell AR, Cillessen L, Salvatore D, Steuber TD. Impact of a blinded journal club on student pharmacist knowledge and retention. Curr Pharm Teach Learn. 2026;18(9):102690. https://doi.org/10.1016/j.cptl.2026.102690
  • Stropes A, Lautenschlager C, Smith AJ, Steuber TD, et al. Linezolid versus clindamycin for toxin inhibition in severe skin and soft tissue infections: a systematic review and meta-analysis. Infection. 2026;54(2):877-885. https://doi.org/10.1007/s15010-025-02722-6
  • Thayer B, Reese MK, Nelson TB, Bran AA, Steuber TD. Building a culture of stewardship: the role of infectious diseases pharmacists in promoting documentation across pharmacy teams. J Am Coll Clin Pharm. 2026;9(4):e70203. https://doi.org/10.1002/jac5.70203
  • Tran BAC, Miller T. Hypomagnesemia from malabsorption and renal magnesium wasting treated with high-dose magnesium glycinate: a case report. J Am Pharm Assoc. 2026 Aug 7. [Epub ahead of print]. https://doi.org/10.1016/j.japh.2026.103496
  • Tran HN, Habtezion M, Zough F, et al. Impact of a multidisciplinary care model with clinical pharmacist involvement on DOAC dosing appropriateness in nonvalvular atrial fibrillation. EC Pharmacol Toxicol. 2026;14(3):1-8.
  • Harris J, Tran HN, Lebada L, et al. Real-world use of intravenous iron therapy and associated clinical outcomes in patients with heart failure and iron deficiency. Ann Pharmacother. 2026;59(suppl):10600280261452584. https://doi.org/10.1177/10600280261452584
  • Terpening CM, Wietholter JP. Dihydroergotamine intranasal powder for acute migraine treatment. Ann Pharmacother. 2026;60(7):715-719. https://doi.org/10.1177/10600280251388440

Presentations

  • Emily Buatois: Hidden in plain sight: how thread champions weave curricular threads to strengthen the PharmD fabric. Presented at: AACP Annual Meeting; July 2026; Grapevine, TX.
  • Sally Falahat: Management of antithrombotic therapy for geriatric patients. Presented at: Illinois Council of Health-System Pharmacists Spring Meeting; March 2026; Chicago, IL.
  • Cait Gibson:
    • Anticoagulation in practice: stewardship, safety, and emerging indications. Presented at: Sentact Center for Clinical Excellence Safety Topics Webinar Series; May 2026; virtual.
    • Chronic care in cardiology. Presented at: American College of Clinical Pharmacy Annual Updates in Therapeutics® Webinar; May 2026; virtual.
    • Anticoagulant use among special populations. Presented at: Taiwan American College of Clinical Pharmacy Annual Meeting; March 2026; Taipei, Taiwan (virtual).
  • Jimmy Gonzalez: Hidden hours: national survey of time spent in preparation of course materials among US pharmacy faculty. Presented at: Monash Pharmacy Education Symposium; July 2026; Prato, Italy.
  • Haley Johnson:
    • Effect of terlipressin versus octreotide/midodrine on mortality in patients with hepatorenal syndrome. Presented at: Society of Critical Care Medicine Critical Care Congress; March 2026; Chicago, IL.
    • Grits in the mornin’: building wellness, resilience, and grit in learners and preceptors. Presented at: ASHP Pharmacy Futures; June 2026; St. Louis, MO.
  • Thaddeus McGiness: New frontiers in hyperkalemia care: the role of managed care professionals and novel potassium binders. Presented at: Academy of Managed Care Pharmacy (AMCP) Annual Meeting; March 2026; Nashville, TN.
  • Cavan O’Kane: Easing off, not cutting off: the evidence and role of pharmacists in opioid tapering. Presented at: NJPhA/GSPO 2026 Spring Symposium; April 2026; Morristown, NJ.
  • Jennifer A. Szwak: Unlocking your preceptor potential: fueling your well-being and success. Presented at: Maryland Society of Health-System Pharmacists Spring Meeting; April 2026; Towson, MD.
  • Bao Anh Tran: Using AI in everyday workflows: practical, human-centered applications. Presented at: American Association of Colleges of Pharmacy Technology in Pharmacy Education and Practice Special Interest Group (SIG); May 2026; virtual.

Other Notable Achievements

  • Mary Teresa Ambrosini: Reviewer, Journal of the American Heart Association.
  • Nicole Metzger: Invited to be an Associate Editor of NEJM Clinician (formerly Journal Watch).
  • Beth Resman-Targoff: Coauthor of course with Ibtissam Gad. A5: Advances in Pharmacologic Management of Rheumatic Conditions, Advanced Rheumatology Course, American College of Rheumatology/Association of Rheumatology Professionals, July 2026.

Ambulatory Care PRN

Promotions

  • Ashlyn Aguiniga: Associate Professor of Pharmacotherapy, University of North Texas System College of Pharmacy and Health Professions.
  • Helen (Nellie) Berlie: Professor, Clinical, Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences.
  • Sarah Billups: Clinical Professor, University of Colorado Anschutz Skaggs School of Pharmacy & Pharmaceutical Sciences.
  • Logan Franck: Clinical Associate Professor, University of Nebraska Medical Center College of Pharmacy.
  • Lara Kerwin: Clinical Pharmacist Specialist Supervisor, BJC Health.
  • Elizabeth Van Dril: Clinical Associate Professor, University of Illinois Chicago Retzky College of Pharmacy.

Awards

  • Lauren Cunningham: 2026 ACCP Ambulatory Care PRN MeRIT Scholarship Recipient.
  • Mate Soric:
    • Class of 2026 Commencement Hooder, Northeast Ohio Medical University.
    • Olson/Blair Award for Administrative Excellence, Northeast Ohio Medical University.

Grants

  • Sharmon P. Osae: PCP HELPR CDTM Toolkit. National Association of Chain Drug Stores Foundation Innovation Award. Principal Investigator ($20,000).
  • Sarah E. Wheeler: Enhancing Realism in Interprofessional Geriatric Escape Room-Style Simulation to Strengthen Team-Based Care for Older Adults. Virginia Center on Aging Geriatric Training and Education Grant. Co-Principal Investigator ($20,786).

Publications

  • Billups SJ, Fraumeni BR, Bauguess HD, et al. Improving access to rheumatology care: evaluation of a rheumatology electronic consultation program. Arthritis Care Res. 2026;78(7):883-892. https://doi.org/10.1002/acr.70003
  • Pai VB, Barnes K, Billups SJ, Chisholm-Burns M, Heil EL, Hemenway AN, Kliethermes MA, Kroon L, Le J, Lu K, Morello CM, Nonyel NP, Olson AW, Slain D, Tsourounis C, Wargo R, et al. Building on the 2025 National Academies Pharmacy Workshop: Health systems financially supported pharmacist roles. Health Affairs Scholar. 2026 Aug 7. [Epub ahead of print]. https://doi.org/10.1093/haschl/qxag204
  • Salanio G, Fraumeni B, Linnebur SA, Billups S, et al. Qualitative assessment of provider perceptions of Medicare annual wellness visits (AWVs). Am J Health Promot. 2026 Jan 28. [Epub ahead of print]. https://doi.org/10.1177/08901171261421321
  • Carris NW, Evoy K, Hughes J, Philbrick A, Singh-Franco D, Lipari M. Comment on “Adopting race-free estimated glomerular filtration rate for unifying medication-related decision-making: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy.” J Am Coll Clin Pharm. 2026;9(4):e70204. https://doi.org/10.1002/jac5.70204
  • Finks SW. Dyslipidemia. In: Franks A, Marrs J, Parker RB, et al, eds. The APhA Complete Review for Pharmacy. 14th ed. American Pharmacists Association; June 2026:chap 16. https://doi.org/10.21019/9781582123875.ch16
  • Finks SW. Update on the 2025 American College of Cardiology/American Heart Association (ACC/AHA) Multi-Society Hypertension Guideline. Pharmacotherapy: Principles and Practice. PPP Updates. McGraw-Hill Companies; 2025.
  • Finks SW, Cieri-Hutcherson NE, Vernon V, et al. Menopausal hormone therapy: a narrative review of contemporary evidence. Pharmacotherapy. 2026;46(7):e70178. https://doi.org/10.1002/phar.70178
  • DiDomenico RJ, Dobesh PP, Finks SW. Acute coronary syndrome. In DiPiro JT, Yee GC, Posey LM, et al, eds. Pharmacotherapy: A Pathophysiologic Approach. 13th ed. McGraw Hill; 2026:chap 37.
  • Harrigfeld S, Cunningham L, Van Dril L. Pharmacist intervention for safer prescribing in patients with type 2 diabetes at high risk: a randomized clinical trial [comment]. JAMA Netw Open. 2026;9(2):e2559946. https://doi.org/10.1001/jamanetworkopen.2025.59946
  • Caballes N, Aneziris C, Hiemenz S, Rathod CS, McQuade Hudak B. ADVANCE-ing patient care: implementation of the academic detailing program Illinois ADVANCE. J Am Pharm Assoc (2003). 2026;66(1):102904. https://doi.org/10.1016/j.japh.2025.102904
  • Hughes J, Ramey O, Khaimova R, Wargo R, Aguiniga A, Amering S, Baalmann A, Bucheit JD, Chaudhry F, Claborn M, Erdman D, Evoy K, Hearn E, Horace A, Huppert C, Ishak AM, Jones E, Keedy C, Kostoff M, Lavender D, Lingow S, Marrs J, Mohammad I, Painter N, Pitlick M, Prudencio J, Riccio K, Sherrill CH, Schumacher C, Smithgall S, Vazquez A, Van Dril E, Wesling M, Westberg S, Wheeler SE, Winter B, Zeng Y (as part of the Advancing Pharmacist Payment Parity Workgroup). State of the union 2026: State-level updates and national trends in pharmacist payment reform. J Am Coll Clin Pharm. 2026;9(6):e70214. https://doi.org/10.1002/jac5.70214
  • Haas K, Saseen J, Titus O, Lamberton N, Schilling LM, Hogan K, Marks A, Billups SJ. Blood pressure control among adherent versus nonadherent Medicare patients with hypertension. Am J Manag Care. 2026;32(7):e228-e233. https://doi.org/10.37765/ajmc.2026.89987
  • Lipari M. Pulmonary disorders. In: ACCP/ASHP 2026 Ambulatory Care Pharmacy Preparatory Review and Recertification Course. American College of Clinical Pharmacy; 2026:655-715.
  • Lipari M, Garwood CL, Berlie H, et al. Clinician perceptions of therapeutic inertia in type 2 diabetes mellitus: a qualitative study. J Am Coll Clin Pharm. 2026;9(2):e70146. https://doi.org/10.1002/jac5.70146
  • Ammar A, Sorochak N, Paxton R, Lipari M, et al. Long-acting insulin and hypoglycemia in critically ill patients with diabetes: a sensitivity analysis. J Intensive Care Med. 2026 Jul 6. [Epub ahead of print]. https://doi.org/10.1177/08850666261462876
  • Dacon C, Kale-Pradhan P, Lipari M. Assessing the impact of glucagon-like peptide-1 and glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor agonist shortages on glycemic control: a single center study. J Pharm Pract. 2026 May 5. [Epub ahead of print]. https://doi.org/10.1177/08971900261449175
  • Penny B, Lipari M, Gutenschwager D, et al. Assessment of comprehensive medication management incorporating a patient-completed medical and medication history (MMH) form in community practice. J Am Pharm Assoc (2003). 2026;66(5):103476. https://doi.org/10.1016/j.japh.2026.103476
  • Lobkovich A, Ferrari H, Martirosov AL, Mohammad I, Berlie H, Garwood C, Lipari M. Aspirin deprescribing interventions for primary prevention: a systematic review. Pharmacotherapy. 2026;46(3):e70121. https://doi.org/10.1002/phar.70121
  • McFarland MS, Finks SW, Zagel A, et al. Building the practice foundations to deliver comprehensive medication management. J Am Coll Clin Pharm. 2026;9(5):e70218. https://doi.org/10.1002/jac5.70218
  • Purathur S, Shah Dave S, Osis L, Cheetany D, Madhiwala A, Patel C, Griffin T, McQuade Hudak B. The impact of academic detailing on clinician and patient outcomes: a narrative review. J Pharm Pract. 2026 May 29. [Epub ahead of print]. https://doi.org/10.1177/08971900261450822
  • Pervanas HC, Mukherjee SM, Silva M. Self-regulated learning behavior clusters associated with NAPLEX readiness exam performance during advanced pharmacy practice experiences, Am J Pharm Educ. 2026;90(10):102050. https://doi.org/10.1016/j.ajpe.2026.102050
  • Osae SP, Chastain DB. Gaps between intended learning and practice in PGY1 pharmacy residency programs: alignment of training experiences with accreditation standards. J Pharm Pract. 2026. [In press]
  • Bradley KE, Chastain DB, Young HN, Osae SP. From pen to prompt: navigating LLM-generated content in postgraduate pharmacy training applications. Am J Pharm Educ. 2026;90(3):101947. https://doi.org/10.1016/j.ajpe.2026.101947
  • Lobo I, Koon K, Potthast K, Ozmina K, Billups SJ. A multi-intervention approach to blood pressure control: a description of how a large university based primary care clinic tackled hypertension. Popul Health Manag. 2026;26(1):18-26. https://doi.org/10.1177/19427891251393941
  • Salvo MC, Polomoff CM. PSAP in JACCP: Case series: osteoporosis. J Am Coll Clin Pharm. 2025;8(12):1370-1371.
  • Alvarez N, Salvo MC. Behind the scoresheet: reviewers’ insight for standout honors and scholarship applications. Am J Health Syst Pharm. 2026 Jun 10. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxag175
  • Fredrickson ME, Barrickman A, Donohoe KL, Goodhart AL, Ko CL, Malcom DR, Romanelli F, Salvo MC. A deimplementation framework for curricular hoarding in pharmacy education. Am J Pharm Educ. 2026;90(5):101968. https://doi.org/10.1016/j.ajpe.2026.101968
  • Luciano J, Nigro S, Salvo M, et al. Using the ACCP Toolkit to evolve the PharmD curriculum. Am J Pharm Educ. 2026;90(4):101959. https://doi.org/10.1016/j.ajpe.2026.101959
  • Sobieraj DM, Luciano J, Nigro S, Salvo M, et al. Response to Salman regarding “Using the ACCP Toolkit to evolve the PharmD curriculum.” Am J Pharm Educ. 22 June 2026. [Epub ahead of print]. https://doi.org/10.1016/j.ajpe.2026.102032
  • Wardwell B, Salvo MC, Carey J. Impact of pharmacist intervention to promote adult human papillomavirus (HPV) vaccination in a primary care clinic. J Am Pharm Assoc (2003). 2026;66(3):103083. https://doi.org/10.1016/j.japh.2026.103083
  • Skory B, Arko J, Terkawi L, Slusarz E, King O, Deokarran C, Glista K, Will M, Etemadi H, Brosch E, Wasowski E, Soric MM. Prevalence of beta blocker prescribing for hypertension. J Pharm Technol. 2026;42(3):115-122. https://doi.org/10.1177/87551225261417534
  • Vergara M, Soric MM, King O, et al. Prescribing patterns of gabapentinoids in patients with chronic obstructive pulmonary disorder. COPD. 2026;23(1):2596683. https://doi.org/10.1080/15412555.2025.2596683
  • Van Dril E, Schumacher CA. Diabetic kidney disease. In: Cornell S, Miller DK, Urbanski P, eds. The Art and Science of Diabetes Care and Education. 7th ed. Association of Diabetes Care and Education Specialists; 2026:791-822.
  • Landup D, Hanners Dunn E, Van Dril E, et al. The cost conundrum: pharmacists at the crossroads of evidence and affordability. J Am Coll Clin Pharm. 2026;9(2):e70181. https://doi.org/10.1002/jac5.70181
  • Salama S, Bolch C, Landup D, Van Dril E, Schumacher C. Factors that influence blood pressure changes with the use of sodium-glucose cotransporter 2 inhibitors in people with type 2 diabetes. Pharmacotherapy. 2026;46(6):e70156. https://doi.org/10.1002/phar.70156
  • Wheeler SE, Lennon A, Switzer D. Impact of pharmacist-managed diabetes care on clinical outcomes in rural health clinics. Ann Pharmacother. 2026 May 6. [Epub ahead of print]. https://doi.org/10.1177/10600280261446051
  • Bucheit JD, Wheeler SE. Pharmacotherapy: other diabetes-related conditions. In: Cornell S, Miller DK, Urbanski P, eds. The Art and Science of Diabetes Care and Education. 7th ed. Association of Diabetes Care and Education Specialists; 2026:535-578.
  • Ayers H, Thomas KC, Wilcox L, Uppuluri EM. Impact of food and travel barriers on warfarin management: a retrospective cohort analysis. J Am Coll Clin Pharm. 2026;9(8):e70267. https://doi.org/10.1002/jac5.70267

Presentations

  • Ashlyn Aguiniga: From pancreas to powerhouse: GLP-1’s evolution beyond diabetes. Presented at: Texas Society of Health-System Pharmacists Annual Seminar; April 2026; Galveston, TX.
  • Lauren Cunningham:
    • Module 11: Ambulatory care roles in diabetes, subsection: population health. Presented at: American Society of Health-System Pharmacists Diabetes Management Certificate; May 2026; virtual.
    • Module 11: Ambulatory care roles in diabetes, subsection: application of population health data. Presented at: American Society of Health-System Pharmacists Diabetes Management Certificate; May 2026; virtual.
    • Bean there, done that: optimizing kidney health in people with diabetes. Presented at: Association of Diabetes Care and Education Specialists Annual Meeting; August 2026; Columbus, OH.
  • Shannon W. Finks:
    • Interdisciplinary knowledge and perceptions of pharmacist involvement in supplement use for menopausal care. Presented at: ACCP 2026 Virtual Poster Symposium; May 20, 2026; virtual.
    • Supraphysiologic testosterone concentrations and androgenic adverse effects after subcutaneous testosterone pellet therapy in menopausal women: a retrospective case series. Presented at: ACCP 2026 Virtual Poster Symposium; May 20, 2026; virtual.
    • Menopause 101. Presented at: FreeCE.com webinar series; June 15, 2026, and July 15, 2026; virtual.
  • Melissa Lipari: Pulmonary disorders. Presented at: 2026 ACCP/ASHP Ambulatory Care Pharmacy Preparatory Review and Recertification Course; 2026; virtual.
  • Sharmon P. Osae: Diabetes dynamics: mastering the management of type 2 diabetes. Presented at: Flint River Nurse Practitioners Association Pharmacology Conference & Update; March 2026; Albany, GA.
  • Marissa Salvo:
    • In the spotlight: pharmacists. Presented at: American Pharmacists Association 2026 Annual Meeting and Exposition; March 2026; Los Angeles, CA.
    • Impact of pharmacist intervention on chronic kidney disease screening and optimization of guideline directed medical therapy in adult patients with type 2 diabetes. Presented at: CSHP’s The Great Eight Residency Showcase; June 2026; West Hartford, CT.
    • Impact of pharmacist-led identification and reconciliation of high-risk and potentially inappropriate medications (PIMs) in elderly patients. Presented at: CSHP’s The Great Eight Residency Showcase; June 2026; West Hartford, CT.
  • Christie Schumacher:
    • Guidelines for non-insulin medication management in patients with type 2 diabetes. Presented at: ADCES Webinar; February 2026; virtual.
    • Integrated care: diabetes guideline updates and the cardio-kidney-metabolic (CKM) syndrome. Presented at: CEImpact; February 2026; virtual.
  • Liz Van Dril:
    • Bean there, done that: optimizing kidney health in people with diabetes. Presented at: Association of Diabetes Care and Education Specialists Annual Meeting; August 2026; Columbus, OH.
    • Screening rates and guideline-directed medical therapy use for chronic kidney disease in people with type 2 diabetes. Abstract 2704-LB. Presented at: American Diabetes Association 86th Scientific Sessions Poster Session; June 2026; New Orleans, LA.
    • Module 6: Diabetes treatment for patients with cardiovascular and renal disease. Presented at: American Society of Health-System Pharmacists Diabetes Management Certificate; May 2026; virtual.
    • Module 4: Billing & reimbursement methods and opportunities for pharmacist patient care clinical services. Presented at: American Society of Health-System Pharmacists Billing and Reimbursement for Patient Care Clinical Services Certificate; June 2026; virtual.
  • Ryan Wargo: Implementation of pharmacists as part of the CKM interprofessional care team. Presented at: National Kidney Foundation Spring Clinical Meeting; May 2026; New Orleans, LA.
  • Sarah E. Wheeler:
    • Advancing MASLD care: a DCES guide to managing MASLD in people with diabetes. Presented at: ADCES Webinar; June 2026; virtual.
    • ACC recap: CORALreef AddOn. Presented at: ACCP Cardiology PRN ACC Recap Webinar; April 2026; virtual.
    • The future of feedback: AI-assisted SOAP note grading. Presented at: VCU 2026 Health Sciences Education Symposium; March 2026; Richmond, VA.
    • A MASH-up of therapies. Integrating new guidelines and therapies for metabolic dysfunction-associated steatohepatitis. Presented at: Virginia Society of Health-System Pharmacists Spring Seminar; March 2026; Williamsburg, VA.
    • The weight is over: new guidelines for obesity management in 2025. Presented at: Virginia Society of Health-System Pharmacists Spring Seminar; March 2026; Williamsburg, VA.

Other Notable Achievements

  • Anna Love: Appointed as Chair of the Tennessee Society of Ambulatory Care Pharmacists.
  • Christie Schumacher: Appointed to the American Diabetes Association Professional Practice Committee, which is responsible for developing and updating the ADA Standards of Care in Diabetes and overseeing ADA consensus reports and scientific statements.

Cardiology PRN

Promotions

  • Rachel Lucas: Clinical Associate Professor, Binghamton University, School of Pharmacy and Pharmaceutical Sciences.

Awards

  • William Baker: University of Connecticut School of Pharmacy Teacher of the Year, 2025-2026.
  • Rob DiDomenico, Erika L. Hellenbart: Paper recognized by Wiley as “Top Cited Article” as one of the top 10 most-cited papers published in Pharmacotherapy in 2024: Hellenbart EL, Ipema HJ, Rodrigues-Ziccardi MC, Krishna H, DiDomenico RJ. Disease-modifying therapies for amyloid transthyretin cardiomyopathy: current and emerging medications. Pharmacotherapy 2025;45(2):122-144. https://doi.org/10.1002/phar.4639
  • Rachel Lucas: NYSCHP New Practitioner Award, 2026.
  • Henry Okoroike: Rush Medical College, Division of Translational Science: Excellence in Clinical Research Award Winner 2026, Chicago, IL.
  • Tom Szymanski: WVU School of Pharmacy APPE Preceptor of the Year, 2025-2026.

Grants

  • Jim Coons: Selexipag Treatment Persistence and Pharmacogenomics. ACCP Cardiology PRN Seed Grant. Principal Investigator ($8000).
  • Henry Okoroike: Prospective Implementation of Pharmacist-Provider Collaboration for Outpatient IV Iron in Heart Failure. American Regent Investigator Initiated Study Grant. Principal Investigator ($75,000).

Publications

  • Alashqar MT, Nahata MC. Fitusiran: a novel antithrombin-targeting therapy for hemophilia A and B, with or without inhibitors. Ann Pharmacother. 2026;60(7):700-709. https://doi.org/10.1177/10600280251403512
  • Alashqar MT, Nahata MC. Reconsidering metabolic adaptation in weight loss evidence: insights and potential limitations of tirzepatide-induced fat oxidation. Metab Target Organ Damage. 2026;6:18. https://doi.org/10.20517/mtod.2025.235
  • Leaman A, Liu L, Alashqar MT, et al. Efficacy and safety of combination pharmacotherapies with standard diuretic therapy in acute heart failure: a systematic review and meta-analysis. Cardiol Rev. 2026 Jun 18. [Epub ahead of print]. https://doi.org/10.1097/CRD.0000000000001337
  • Butt F, Chokshi P, Badua PM, et al. Diagnostic evolution from channelopathy to idiopathic ventricular fibrillation after aborted sudden cardiac death. JACC Case Rep. 2026;31(18):107624. https://doi.org/10.1016/j.jaccas.2026.107624
  • Mogga B, Raol K, Pillai A, Baker WL, et al. Short-term care burden after left ventricular assist device implantation and heart transplant in the United States. J Am Heart Assoc. 2026;15(5):e043588. https://doi.org/10.1161/JAHA.125.043588
  • Coons JC, Polkowski K, Prebehalla L, et al. ABCD-GENE score and bleeding in post-PCI patients: implications for guided de-escalation of antiplatelet therapy. J Cardiovasc Pharmacol Ther. 2026;31. https://doi.org/10.1177/10742484261457268
  • Smith ZR, Kelly B, Wu S, Raymond-Forde S, Coons JC. Pulmonary arterial hypertension: focused therapeutic update. Am J Health Syst Pharm. 2026 Apr 6. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxag102
  • DiDomenico RJ, Dobesh PP, Finks SW. Acute coronary syndromes. In: Haines ST, Nolin TD, Ellingrod VL, et al, eds. DiPiro’s Pharmacotherapy: A Pathophysiologic Approach. 13th ed. 2026:chap 37.
  • DiDomenico RJ, Marrs JC, Bress AP, Denfeld QE, Dobesh PP, et al. Deprescribing in patients with cardiovascular disease experiencing polypharmacy: a statement from the American Heart Association. Circulation. 2026;154(8). [Epub ahead of print]. https://doi.org/10.1161/CIR.0000000000001459
  • Vest AR, DiDomenico RJ, Lichtenstein L, et al. Malnutrition and cachexia in inpatients with acute cardiac conditions: a scientific statement from the American Heart Association. Circulation 2026;153(13):e1078-e1105. https://doi.org/10.1161/CIR.0000000000001405
  • Dobesh PP, DiDomenico RJ, Rogers KC. Chronic coronary disease. In: Haines ST, Nolin TD, Ellingrod VL, et al, eds. DiPiro’s Pharmacotherapy: A Pathophysiologic Approach. 13th ed. 2026:chap 36.
  • Ehret JA. Rethinking antithrombotic therapy for LVADs: is less more? Pharmacy Times. 2026;15(3):32-34. https://www.pharmacytimes.com/view/rethinking-antithrombotic-therapy-for-lvads-is-less-more-
  • Gibson CM, Escaño AK, Hobe KD, et al. Safety and effectiveness of somatostatin and analogues on chest tube output after coronary artery bypass grafting: a scoping review. J Cardiovasc Pharmacol. 2026;88(2):155-160. https://doi.org/10.1097/FJC.0000000000001810
  • DiVall MV, Dey S, Dang D, Gibson CM, et al. Flexible work arrangements in pharmacy academia: an overdue imperative. Am J Pharm Educ. 2026;90(9):102039. https://doi.org/10.1016/j.ajpe.2026.102039
  • O’Connell MB, Prescott GM, Allen M, Connor SE, Ford E, Formea CM, Gibson CM, Goodlet KJ, Jellinek-Cohen S, Mukherjee SM, Munir F, Nguyen-Klatt JV, Pai V, Tungate Lopez S, et al. ACCP White Paper: From awareness to action: increasing health equity by addressing cultural and structural barriers in pharmacy practice, education, and research. J Am Coll Clin Pharm. 2026;9:e70206. https://doi.org/10.1002/jac5.70206
  • Ayers H, Groo VL, DiDomenico RJ, Kaluzna SD, Alaraj AA, Tofovic D, Duckett M, Hellenbart E. Missed opportunities to intensify lipid-lowering therapy in patients with atherosclerotic cardiovascular disease: a retrospective cohort study. J Am Coll Clin Pharm. 2026;9(5):e70209. http://dx.doi.org/10.1002/jac5.70209
  • Collins CD, Veve MP, Hollis IB. Rise of the machines: comparing performance of artificial intelligence large language models on pharmacy specialty certification examination practice questions. J Am Coll Clin Pharm. 2026;9(5):e70215. https://doi.org/10.1002/jac5.70215
  • Olsen KM, Borchert JS, Bookstaver PB, Chahine EB, Connor KA, Cook AM, Dye M, Dull R, Hawkins WA, Adams KK, Doloresco F, Hamada H, Hollis IB, et al. Importance of residency training for provision of comprehensive clinical pharmacy services. J Am Coll Clin Pharm. 2026;9(6):e70217. https://doi.org/10.1002/jac5.70217
  • Huang X, Baker WL, Colombo PC, Yuzefpolskaya M, Jennings DL. Contemporary immunosuppression in dual organ heart transplantation: a United Network for Organ Sharing database analysis. Pharmacotherapy. 2026;46(5):e70144. https://doi.org/10.1002/phar.70144
  • Goonewardena SN, Yao S, Jurga T, et al. Lipoprotein(a)-associated proteomic signature predicts cardiovascular disease in young adults. J Clin Invest. 2026;136(12):e204287. https://doi.org/10.1172/JCI204287
  • Steverson AB, Fan J, Din N, Kalwani N, Varshney AS, Verma A, Bosworth HB, Jurga T, et al. Differences in guideline directed medical therapy for rural and non-rural veterans with heart failure with reduced ejection fraction. Am Heart J. 2026;293:107300. https://doi.org/10.1016/j.ahj.2025.107300
  • Salama S, Bolch C, Landup D, Van Dril E, Schumacher C. Factors that influence blood pressure changes with the use of sodium-glucose cotransporter 2 inhibitors in people with type 2 diabetes. Pharmacotherapy. 2026;46(6):e70156. https://doi.org/10.1002/phar.70156
  • Nasuhidehnavi A, Lucas RC, Bach K, et al. Etripamil: the first FDA-approved intranasal L-type calcium channel blocker for acute termination of paroxysmal supraventricular tachycardia. Ann Pharmacother. 2026 Jul 8. [Epub ahead of print]. https://doi.org/10.1177/10600280261454696
  • Carr J, Sikora A, Meyer SA, et al. Individualized de-resuscitation and diuresis strategies in hospitalized patients: a narrative review. Am J Health Syst Pharm. 2026;83:e171-e182. https://doi.org/10.1093/ajhp/zxaf217
  • Montepara CA, Gordon AL, Gdula JM, et al. Description of treatment strategies and patient outcomes for hospitalized patients with lyme carditis. Ann Pharmacother. 2026 Jul 13. [Epub ahead of print]. https://doi.org/10.1177/10600280261458227
  • Zachariah S, Nabil S, Thomas A, et al. Clinical pharmacists’ aspirations on prescribing in cardiology within an academic health system. Explor Res Clin Soc Pharm. 2026;23:100804. https://doi.org/10.1016/j.rcsop.2026.100804
  • Tesoro N, Marsidi J, Spaan J, Okoroike H, et al. Identifying patients at risk of Takotsubo syndrome during cancer treatment: a sex-based cardio-oncology review. Expert Rev Cardiovasc Ther. 2026 Aug 5. [Epub ahead of print]. https://doi.org/10.1080/14779072.2026.2714263
  • Dumont Z, Rogers KC, Alhammad AM, Coons JC, Dager WE, Edwards ME, Higgins T, Miesner AR, Pon T, et al. Value of inpatient clinical pharmacists. ACCP Clinical Practice Affairs Committee. J Am Coll Clin Pharm 2026;9:e70230. https://doi.org/10.1002/jac5.70230
  • Raghupathy R, Schenk A, Shapero K. Heart failure medication recommendations during pregnancy and breastfeeding. Latest in Cardiology. American College of Cardiology. May 4, 2026. https://www.acc.org/Latest-in-Cardiology/Articles/2026/05/04/12/18/Heart-Failure-Medication-Recommendations-During-Pregnancy-and-Breastfeeding
  • Ganter M, Bowyer M, Relic E, Sickley R, Warner M, Baker WL, Hollis IB. Impact of selective serotonin reuptake inhibitors on bleeding rates in HeartMate 3 left ventricular assist device patients not taking aspirin. Artif Organs. 2026;50(6):924-930. https://doi.org/10.1111/aor.70078
  • Alhurayri F, Younis IR, Jalal SI, Logan TF, Maniar R, Bray SM, Quinney SK, Desta Z, Skaar TC, Tisdale JE, et al. Pharmacokinetic drug-drug interaction potential of oral anticancer drugs. Clin Pharmacol Ther. 2026;119(6):1614-1627. https://doi.org/10.1002/cpt.70253
  • Torbey E, Cheung JW, Asad ZUA, Tamarisa K, Tisdale JE, et al. Arrhythmias and cardiac device management in oncology patients. Heart Rhythm. 2026;23(7):1646-1658. https://doi.org/10.1016/j.hrthm.2026.03.1944
  • Yang M, Zhang L, Kote A, Fisher C, Tisdale JE, et al. Sex-dependent activation of apamin-sensitive small-conductance Ca2+-activated K+ current by ß-1 adrenoceptor stimulation in rabbit ventricles. J Physiol. 2026 Mar 31 [Epub ahead of print]. https://doi.org/10.1113/JP291047
  • Van Tuyl JS, Di Palo KE, Huynh T, Joy JP, Kemp L, et al. Acoramidis for the management of transthyretin amyloid cardiomyopathy: clinical evidence and implications for pharmacist-led care. Am J Health Syst Pharm. 2026 Jun 22. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxag181
  • Wences M, Okoroike H, Bernier T, et al. Validation of a novel guideline directed medical therapy (GDMT) scoring tool to optimize therapy for patients with heart failure with reduced ejection fraction (HFrEF). Ann Clin Cardiol. 2026;8(2):96-101. https://doi.org/10.4103/ACCJ.ACCJ_7_26

Presentations

  • Mohammad Alashqar:
    • Clinical impact of digital health education for patients with heart failure: a systematic review and meta-analysis. Presented at: The 1st International Online Conference on Healthcare 2026; March 2026; virtual.
    • Fitusiran: a novel antithrombin-targeting therapy for hemophilia A and B, with or without inhibitors. Presented at: THSNA Conference 2026; March 2026; Portland, OR.
    • Cost-effectiveness of fitusiran prophylaxis versus factor VIII on-demand or prophylactic therapy for patients with hemophilia A without inhibitors. Presented at: ISPOR 2026 International Meeting; May 2026; Philadelphia, PA.
  • William Baker: Complementary and alternative medicine strategies for SIHD: what’s the evidence and the role? Presented at: American College of Cardiology Annual Scientific Session; March 28, 2026; New Orleans, LA.
  • Jim Coons:
    • ABCD-GENE score and bleeding in post-PCI patients: implications for guided de-escalation of antiplatelet therapy. Presented at: American College of Cardiology Annual Meeting; March 28, 2026; New Orleans, LA.
    • Right heart, real decisions—case-based approaches to managing complexity in pulmonary hypertension. Presented at: American College of Cardiology Annual Meeting; March 28, 2026; New Orleans, LA.
    • PaACC CardioLaunch: Collaborating in a multidisciplinary team. Presented at: Pennsylvania Chapter of the American College of Cardiology (PaACC); April 14, 2026; virtual.
  • Rob DiDomenico:
    • Polypharmacy and potential for drug-drug interactions among patients with ATTR-CM initiating treatment with tafamidis. J Am Coll Cardiol. 2026;87(suppl A):A752. https://www.jacc.org/doi/10.1016/j.jacc.2026.02.1950. Poster presented at: 75th Annual ACC Scientific Session & Expo; March 2026; New Orleans, LA.
    • Medication mismatch: evaluating the association between potentially inappropriate medications and GDMT optimization in HFrEF. J Am Coll Clin Pharm. 2026 [1516]. 2026 ACCP Virtual Poster Symposium; May 2026; virtual.
  • Julie Ehret: Anticoagulation for LVADs—warfarin to stay or apixaban for all? Presented at: American Society for Artificial Internal Organs 72nd Annual Conference; June 18, 2026; Fort Lauderdale, FL.
  • Cait Gibson:
    • Anticoagulation in practice: stewardship, safety, and emerging indications. Presented at: Sentact Center for Clinical Excellence Safety Topics Webinar Series; May 2026; virtual.
    • Chronic care in cardiology. Presented at: American College of Clinical Pharmacy Annual Updates in Therapeutics® Webinar; May 2026; virtual.
    • Anticoagulant use among special populations. Presented at: Taiwan American College of Clinical Pharmacy Annual Meeting; March 2026; virtual.
  • Deema Gichi, Vicki Groo, Rob DiDomenico, Erika Hellenbart, Jessica Tilton, Stephanie Dwyer Kaluzna: Safety of mineralocorticoid receptor antagonists in patients with chronic kidney disease stage 4-5: a retrospective review. J Am Coll Cardiol. 2026;87(suppl A):A1256. https://www.jacc.org/doi/10.1016/j.jacc.2026.02.3099. Poster presented at: 75th Annual ACC Scientific Session & Expo; March 2026; New Orleans, LA.
  • Tomasz Jurga: Pharmacist-led heart failure management in a facility-based home telehealth program. Presented at: American College of Cardiology Conference; March 29, 2026; New Orleans, LA.
  • Sara Anne Meyer: The life of a transcatheter valve replacement: antithrombotic pharmacotherapy. Presented at: Georgia Society of Health-System Pharmacists; March 27, 2026; Savannah, GA.
  • Ashley Schenk: Balancing risk and rhythm: cardiac medications in pregnant and lactating patients. Presented at: American College of Cardiology Webinar; April 28, 2026; virtual.
  • James Tisdale:
    • Ranolazine—solo or combination? Presented at: Annual Meeting of the Heart Rhythm Society; April 24, 2026; Chicago, IL.
    • Safety pharmacology and the heart. Presented at: Annual Meeting of the Heart Rhythm Society; April 25, 2026; Chicago, IL.
    • Drug-induced long QT and proarrhythmia. Presented at: Annual Meeting of the Heart Rhythm Society; April 25, 2026; Chicago, IL.
    • Why metabolism matters in atrial fibrillation: the physiologic bridge between obesity, inflammation & arrhythmia. Presented at: Annual Meeting of the Heart Rhythm Society; April 26, 2026; Chicago, IL.

Other Notable Achievements

  • Rob DiDomenico: Fellow of the American Heart Association (FAHA).
  • Ian B. Hollis: Fellow of the International Society of Heart and Lung Transplantation (ISHLT).
  • Sara Anne Meyer: Associate of the American College of Cardiology (AACC).
  • Said Nabil: BCPS.
  • Christie Schumacher: Appointed to the American Diabetes Association (ADA) Professional Practice Committee, which is responsible for developing and updating the ADA Standards of Care in Diabetes and overseeing ADA consensus reports and scientific statements.

Central Nervous System PRN

Awards

  • Andrew C. Hean: Lauren Y, Pacheco S, Skoglund E, Hean AC. Education & Training PRN Best Poster Award at ACCP Virtual Poster Symposium: Description of Workload Related Residency Components Amongst California Postgraduate Year One and Two Pharmacy Residency Programs.

Publications

  • Heinrich N, Maynard M, Sobhanian M. Primary headache disorders. In: Haines ST, Nolin TD, Ellingrod VL, et al, eds. DiPiro’s Pharmacotherapy: A Pathophysiological Approach. 13th ed. 2026:chap 84.
  • Sangha KS, Jakubecz C, Maynard M, et al. Real world predictors of hypogammaglobulinemia and serious infections in patients receiving ocrelizumab or ofatumumab for the treatment of multiple sclerosis: the REPLACE-MS study. Mult Scler. 2026;32(3):338-346. https://doi.org/10.1177/13524585251412125

Presentations

  • Andrew C. Hean:
    • Novel pharmacotherapy for insomnia: beyond benzodiazepines and Z-drugs. Presented at: UC San Diego Updates in Therapeutics® Conference; June 2026; San Diego, CA.
    • AI versus us or AI for us: rethinking scholarly review writing. Presented at: American Association of Colleges of Pharmacy Annual Meeting; July 2026; Grapevine, TX.
  • Andrew C. Hean, Kelly C. Lee: Integrating pain, mood, and sleep management: interactive case discussions. Presented at: UC San Diego Updates in Therapeutics® Conference; June 2026; San Diego, CA.

Clinical Administration PRN

Promotions

  • Christine Groth: Director, Pharmacy-Acute Care Clinical Services, University of Rochester Medical Center-Highland Hospital.

Awards

  • Tyler Vest:
    • North Carolina Association of Pharmacists Health-System Pharmacists of the Year Award.
    • Board of Pharmacy Specialties Rising Star Award.

Publications

  • Mercado A, Noble JM, Irwin AN, Badowski ME, Bangalore N, Caliendo G, Chan DCM, Dumont ZJ, Groth C, et al. Key performance indicators for clinical pharmacy practice and administration in inpatient/acute care settings: an opinion of the Clinical Administration Practice and Research Network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2026;9(8):e70252. https://doi.org/10.1002/jac5.70252
  • Vanini D, Reid S, Pero E, Rappaport S, Groth C. Impact of pharmacist involvement on hospital sepsis response teams. Am J Health Syst Pharm. 2026 Jul 4. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxag195
  • Boswell E, Ivey MF, Vest TA, et al. Stepping up to unexpected leadership opportunities. Am J Health Syst Pharm. 2026;83(12):602-605. https://doi.org/10.1093/ajhp/zxaf359
  • DiPiro JT, Couldry R, Dopp AL, Kraus T, Vest TA, et al. ASHP and ASHP Foundation pharmacy forecast 2026: strategic planning guidance for pharmacy departments in hospitals and health systems. Am J Health Syst Pharm. 2026;83(2):71-101. https://doi.org/10.1093/ajhp/zxaf247
  • Gazda NP, Peek GK, Vest TA, et al. Bridging the continuity: practice-enhancing publications about the ambulatory care medication use process in 2025. Am J Health Syst Pharm. 2026;83(10):491-507. https://doi.org/10.1093/ajhp/zxag232

Other Notable Achievements

  • Karen Williams: Certificate completion from Harvard Medical School Professional, Corporate, and Continuing Education in Safety, Quality, Informatics, and Leadership.

Community-Based PRN

The Community-Based PRN is celebrating 5 years at the Annual Meeting this fall and is very proud of the space members have created for practitioners and researchers alike working within community spaces.

Awards

  • Emily Eddy:
    • Innovation in Self-Care Teaching Award, AACP Self-Care SIG, July 2026.
    • JACCP Top Viewed Article of 2025, awarded May 2026.
  • Stefanie Ferreri: 2026 Daniel B. Smith Practice Excellence Award, APhA.
  • Rebecca Lahrman: Ohio State University Award for Outstanding Outreach and Engagement.
  • Grace Marley:
    • American Society of Clinical Psychopharmacology New Investigator Award.
    • American Pharmacists Association Generation RX Award of Excellence.
    • Reviewer Choice Award: Symposium for Health Access Research in Southeastern North Carolina.

Grants

  • Okeke N, Bosworth H, Ware K, Ferreri S, et al: Pharmacists for Prevention (P4P): Harnessing the Role of Pharmacists in Ending the HIV Epidemic Through Collaboration with Pharmacy Schools. NIH. August 2025 – August 2030.
  • Michelle Jeon: HIV Testing in Community Pharmacy Settings (Practice grant renewed for 2026-2027). Philadelphia Department of Public Health.
  • Grace Marley: Advancing Pharmacy-Based Methadone Dispensing in the U.S.: Insights from Australia. PharmAlliance Early Career Research Award.

Publications

  • Riley-Jensen EG, Adeoye-Olatunde OA, Zillich AJ, Hubach RD, Snyder ME. Characterizing how community pharmacy teams engage with social drivers of health (SDOH) during routine workflow: a report from the Medication Safety Research Network of Indiana (Rx-SafeNet). J Am Pharm Assoc (2003). 2026;66(5):103474. https://doi.org/10.1016/j.japh.2026.103474
  • Hake KL, Schneider SN, Coley KC, et al. Social determinants of health screening and referral services in community pharmacies: a payor program analysis. J Am Pharm Assoc (2003). 2026;66(4):103109. https://doi.org/10.1016/j.japh.2026.103109
  • Salvati S, McGrath S, Linn K, Kirisci L, Bhosle M, Coley KC. Improving medication adherence in the Medicaid population through community pharmacist-provided services. J Am Pharm Assoc (2003). 2026;66(4):103154. https://doi.org/10.1016/j.japh.2026.103154
  • Daly CJ, Foster A, Chen EL, et al. Expanding access to diabetes self-management and education programs through community pharmacy referrals: a statewide implementation evaluation. J Am Pharm Assoc (2003). 2026;66(5)103464. https://doi.org/10.1016/j.japh.2026.103464
  • Daly CJ, Panthapattu MV, Murray F, et al. Delivering diabetes education and enhanced services within a clinically integrated community pharmacy network. J Pharm Pract. 2026;39(2):93-103. https://doi.org/10.1177/08971900251350509
  • Cellino CAK, Chen EL, Pawelek J, Daly CJ, et al. Pharmacist’s role in addressing barriers to continuous glucose monitoring within underserved communities. J Am Pharm Assoc (2003). 2026;66(2):103016. https://doi.org/10.1016/j.japh.2025.103016
  • Penny B, Lipari M, Gutenschwager DW, Fava J, et al. Assessment of comprehensive medication management incorporating a patient-completed medical and medication history form in community practice. J Am Pharm Assoc (2003). 2026 Jul 2. https://doi.org/10.1016/j.japh.2026.103476
  • Smolen C, Fava J, Kilgore PE. Disparities in adult influenza vaccination in the United States: analysis of 2023 BRFSS data. Infect Dis Ther. 2026;15(9):2545-2560. https://doi.org/10.1007/s40121-026-01396-3
  • Ferreri SP, Bacci JL, Doucette WR, Daly C, McDonough R, Roller J, McGivney MS, Smith MG, Coley KC. Community pharmacy practice transformation: evaluating sustainability of patient care services. J Am Pharm Assoc (2003). 2026;66(3):103084. https://doi.org/10.1016/j.japh.2026.103084
  • Ferreri SP, Brooks A, Cahill J, et al. The socialization of the key elements of practice redesign in community pharmacies: the 2025-2026 AACP Professional Affairs Standing Committee Report. Am J Pharm Educ. 2026;90(8):102029. https://doi.org/10.1016/j.ajpe.2026.102029
  • Busby-Whitehead J, Ferreri SP, Niznik J, et al. A pharmacist consultant service for deprescribing opioids and benzodiazepines in older adults: a cluster randomized trial. JAMA Netw Open. 2026;9(2):e2560581. https://doi.org/10.1001/jamanetworkopen.2025.60581
  • Shen J, Clough C, Cross CJ, Russell R, Hamper J, et al. Awareness and perceptions of community pharmacist-provided clinical services among Illinois health professional students. JAPhA Pract Innov. 2026;3(3):100116. https://doi.org/10.1016/j.japhpi.2026.100116
  • Barde S, Lahrman R, Kissel J, et al. Evaluating the role of pharmacists in providing care with long-acting injectables for HIV and PrEP. J Am Pharm Assoc (2003). 2026;66(4):103149. https://doi.org/10.1016/j.japh.2026.103149
  • Marley G, Mashburn T, Alebrande P, et al. Pilot evaluation of a pharmacist-led technical assistance program to address buprenorphine dispensing in community pharmacies. Explor Res Clin Soc Pharm. 2026;23:100815. https://doi.org/10.1016/j.rcsop.2026.100815
  • Marley GT, Nunnery M, Shubel C, et al. Barriers and facilitators to pharmacy-based methadone dosing and dispensing: semi-structured interviews with pharmacists. J Am Pharm Assoc (2003). 2026;66(5):103472. https://doi.org/10.1016/j.japh.2026.103472
  • Marley GT, Shubel C, Nunnery M, et al. Methadone in community pharmacies: a mixed methods study of board-certified addiction medicine physician and addiction psychiatrist perspectives. J Subst Use Addict Treat. 2026;190:210052. https://doi.org/10.1016/j.josat.2026.210052
  • Johnson J, Annis I, Delamater P, Marley G, et al. Over-the-counter naloxone sales and pricing disparities in North Carolina following FDA approval. J Subst Use Addict Treat. 2026;185:209930. https://doi.org/10.1016/j.josat.2026.209930
  • Johnson JM, Marley GT, Annis IE, et al. Availability and cost of naloxone over time: a longitudinal secret shopper study in North Carolina community pharmacies. J Am Pharm Assoc (2003). 2026;66(5):103459. https://doi.org/10.1016/j.japh.2026.103459
  • Ostrach B, Shubel C, Carpenter D, Marley G. “Methadone at the pharmacy like Suboxone®?… It would untangle a lot of tangles.” Perspectives of North Carolinians with lived experience of opioid use on potential benefits of methadone dispensing at community pharmacies. Subst Use Misuse. 2026 Jun 15. [Epub ahead of print]. https://doi.org/10.1080/10826084.2026.2670621
  • Shubel C, Marley G, Isac A, et al. “With a little help from my friends”—collaborating with community experts to improve sampling and obtain a high response rate for a statewide naloxone availability survey. BMC Public Health. 2026;26(1):1816. https://doi.org/10.1186/s12889-026-27526-7
  • Shubel C, Marley G, Ostrach B, et al. Perspectives from opioid treatment program staff on community pharmacy-based methadone dispensing in North Carolina. J Subst Use Addict Treat. 2026;18:209942. https://doi.org/10.1016/j.josat.2026.209942
  • Shubel C, Nunnery MA, Marley GT, et al. Expanding methadone access through community pharmacies: a qualitative study exploring opioid treatment program staff perceptions of pharmacy-based medication units. Subst Use Addctn J. 2026 May 31. [Epub ahead of print]. https://doi.org/10.1177/29767342261449037
  • Deng M, Ojo C, Riley-Jensen EG, Snyder ME. Developing investigator guidance for pharmacy compensation for research participation: a report from the Medication Safety Research Network of Indiana (Rx-SafeNet). J Am Pharm Assoc (2003). 2026;66(3):103067. https://doi.org/10.1016/j.japh.2026.103067

Presentations

  • Emily Eddy:
    • Well-being in 15 minutes—simple reset strategies for busy pharmacists. Presented at: TTUHSC CE Week for 30th Anniversary Celebration; May 2026; Amarillo, TX.
    • Comparing clinical skills performance and retention between traditional and hybrid pathways. Poster presented at: American Association of Colleges of Pharmacy; July 2026; Grapevine, TX.
    • Faculty perspectives on pharmacy resident roles and impact in skills laboratory education. Poster presented at: American Association of Colleges of Pharmacy; July 2026; Grapevine, TX.
  • Rebecca Lahrman: Evaluation of student pharmacist perceptions through an Appalachian pharmacy service-learning experience. Poster presented at: American Association of Colleges of Pharmacy; July 2026; Grapevine, TX.
  • Grace Marley:
    • Assessing community pharmacist preparedness to implement methadone treatment. Poster presented at: American Society of Clinical Psychopharmacology (ASCP) Annual Meeting; May 2026; Miami, FL.
    • Expanding methadone access to community pharmacies: results from a survey of addiction medicine physicians in North Carolina. Poster presented at: American Pharmacists Association (APhA) Annual Meeting & Exposition; March 2026; Los Angeles, CA.
  • Yen KD, Ferreri SP, Hughes TD, et al. Prescription for participation: recruitment of community-based pharmacists for qualitative and quantitative research. Poster presented at: American Pharmacists Association (APhA) Annual Meeting & Exposition; March 2026; Los Angeles, CA.

Other Notable Achievements

  • Emily Eddy: Selected for 2026-2027 ACCP Professional Leadership Development Program.

Critical Care PRN

Promotions

  • Wasim El Nekidy: Clinical Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH.
  • Jerika Nguyễn-Klatt: Clinical Pharmacy Specialist, Emergency Medicine, Trinity Health Grand Rapids Hospital, Grand Rapids, MI.
  • Kyle Weant: Clinical Assistant Professor, University of South Carolina School of Medicine Greenville, Greenville, SC.

Awards

  • Aeryana Bektas: Education Science Career Development Award, Mayo Clinic Office of Education Research.
  • Kara Birrer: Preceptor of the Year, Orlando Health, Orlando Regional Medical Center.
  • Sarah Blackwell: APPE Preceptor of the Year, Samford University McWhorter School of Pharmacy.
  • Aaron Cook: Wethington Award, University of Kentucky.
  • Jenna Cox:
    • Outstanding Mentor Award, University of South Carolina College of Pharmacy.
    • Acute/General Medicine Preceptor of the Year for the Midlands, Palmetto Experiential Education Partnership – MUSC and USC Colleges of Pharmacy.
  • Sandra Kane-Gill: Distinguished Investigator Award, Society of Critical Care Medicine.
  • Jacob King: Allied Health Junior Provider of the Year, Military Health System, US Navy/Department of Defense.
  • Eric Wasowski: Preceptor of the Year, Ohio College of Clinical Pharmacy.

Grants

  • Aaron Cook: Translational Model for Transdermal Glomerular Filtration Measurement and Cefepime Pharmacokinetics. University of Kentucky Center for Clinical Translation Science. Principal Investigator ($5000).
  • Mojdeh Heavner: Comparing Two Multicomponent ICU Bundles to Promote Sleep and Reduce Delirium in Critically Ill Adults. Patient-Centered Outcomes Research Institute (PCORI). Co-Investigator ($16,853,745).
  • Jerika Nguyễn-Klatt: ACCP Critical Care PRN Multicenter Research Network Grant. Principal Investigator ($7500).

Publications

  • Birrer KL. Acute ischemic stroke and neuroendovascular procedures. In: Smith ZR, Zimmerman LH, eds. Critical Care Self-Assessment Program, 2026. American College of Clinical Pharmacy; 2026:23-58.
  • Bolesta S, Smith KE, Gélinas C, Perreault MM, Burry L, Carini F, Harpel J, Stewart R, Riker RR, Erstad BL, et al. Patterns of opioid and sedative use in adult ICUs: insights from the ALERT-ICU study on iatrogenic withdrawal syndrome. J Crit Care. 2026;93:155444. https://doi.org/10.1016/j.jcrc.2026.155444
  • Cook AM, Cook TS. Pharmacy, family, and faith: our story of commitment and mentorship. Am J Health Syst Pharm. 2026;83(10):513-514. https://doi.org/10.1093/ajhp/zxaf259
  • Cook AM, Harris M, Michas C. Pharmacist’s guide to common intracranial bleeding terms and treatments. Ann Pharmacother. 2026;60(2):181-195. https://doi.org/10.1177/10600280251358676
  • Atkins P, Behal M, Flannery A, Cook AM. Evaluating PICO framework utilization in pharmacy resident research. Am J Health Syst Pharm. 2026; 83(14):765-770. https://doi.org/10.1093/ajhp/zxag042
  • Bruning R, Butts A, Martin C, Bourdet S, Curtin M, Giddens S, Kalus J, Paloucek F, Walker C, Waltman B, Cook AM. Evaluation of differences in postgraduate year one pharmacy residency application rubrics. Pharm Educ. 2026;26(1):127-136. https://doi.org/10.46542/pe.2026.261.127136
  • Farrokh S, Cook AM, Feldman R, et al. Pharmacologic and toxicologic confounders in brain death determination: a multidisciplinary guide. Crit Care. 2026;30:77. https://doi.org/10.1186/s13054-025-05833-6
  • Huntt K, Schadler A, Leonhard A, Scott R, Fraser JF, Lee J, Nestor M, Qureshi A, Cook AM. Blood pressure variability in the ATACH2 study: evaluating a target range. Neurol Sci. 2026;47(4):393. https://doi.org/10.1007/s10072-026-08970-0
  • Kharouba M, Aboelezz A, Elshamy A, Cook AM, Thompson Bastin ML, et al. Development and validation of an HPLC-UV method for the quantification of cefepime in human plasma for routine clinical monitoring. Sep Sci Plus. 2026;9(3):e70202. https://doi.org/10.1002/sscp.70202
  • Duong H, Karnbach M, Keedy C, Henry K, Heavner MS, Murray B, Ghaffari M, Majchrzak J, Swarthout MD, Sikora A, Smith SE. A survey of hospital pharmacy leader perspectives on advocating for clinical pharmacy services. J Am Coll Clin Pharm. 2026;9(6):e70233. https://doi.org/10.1002/jac5.70233
  • El Khatib O, Zekery-Saad S, Abidi E, Abdelaziz A, Abu Tabar O, Ahmed M, Farooq A, El Nekidy WS. Influence of kidney function estimation methods on carboplatin dosing and clinical outcomes. Ann Pharmacother. 2026 Apr 3. [Epub ahead of print]. https://doi.org/10.1177/10600280261430829
  • Aljumaa SA, Al Musawa M, El Lababidi R, Abidi E, Ghazi I, El Nekidy WS. Comment on “Evaluation of high dose post-dialytic versus daily beta-lactam dosing in hemodialysis patients using Monte Carlo simulation.” Int J Clin Pharm. 2026;48(3):1185-1186. https://doi.org/10.1007/s11096-026-02127-x
  • Ghazi IM, Omar AF, El Nekidy WS, et al. Innate immune response to bacterial infections in hospitalized glucose-6-phosphate dehydrogenase-deficient patients; diagnostic value of white blood cell count. Clin Immunol. 2026;282:110613. https://doi.org/10.1016/j.clim.2025.110613
  • Malaeb D, Younes S, Barakat M, Jaber A, El-Labbad EM, Hassan BAR, Salim R, Al-Jewari WM, Mosleh R, Al Ayoubi F, Jawad H, Hallit S, El Said NO, El Nekidy WS. Insights into perceptions, motivations, and barriers toward board certification among pharmacists in middle east countries: a cross-sectional study. J Am Coll Clin Pharm. 2026;9(8):e70256. https://doi.org/10.1002/jac5.70256
  • Younes S, Barakat M, El-Labbad EM, Omar El Said N, Jaber A, Sawan ES, El Nekidy WS, et al. Influence of board-certified preceptors on pharmacy students’ intention to pursue specialty certification. Am J Pharm Educ. 2026;90(9):102042. https://doi.org/10.1016/j.ajpe.2026.102042
  • Erstad BL, Cobas MA, Qadir N, Alshamsi F, Sharif S, Devine EM, Devine ST, Einav S, Elmer J, Fort AC, Harrod CG, Heavner MS, Lamb KD, Mehta S, Mitchell DA, Paruk F, Piraino T, Sacha G, Schell-Chaple HM, Sinha S, Smith SE, et al. Society of Critical Care Medicine guidelines for the administration of neuromuscular blockade in adults with acute respiratory distress syndrome. Crit Care Med. 2026;54(3):634-643. https://doi.org/10.1097/CCM.0000000000007002
  • Erstad BL, Cobas MA, Qadir N, Alshamsi F, Sharif S, Devine EM, Devine ST, Einav S, Elmer J, Fort AC, Harrod CG, Heavner MS, Lamb KD, Mehta S, Mitchell DA, Paruk F, Piraino T, Sacha G, Schell-Chaple HM, Sinha S, Smith SE, et al. Executive summary: Society of Critical Care Medicine guidelines for the administration of neuromuscular blockade in adults with acute respiratory distress syndrome. Crit Care Med. 2026;54(3):630-633. https://doi.org/10.1097/CCM.0000000000007001
  • Sirimaturos MW, Honarmand K, Long MT, Preiser JC, Nagpal AD, Agus MSD, Aldouhan J, Bircher NG, Carpenter DL, Dearness K, Farrington EA, Freire AX, Hirshberg EL, Irving SY, Krinsley JS, Lanspa MJ, Prager R, Srinivasan V, Umpierrez GE, Wax SP, Jacobi J. Comparison of intensive versus conventional glycemic control targets: an updated systematic review and meta-analysis of the 2024 Society of Critical Care Medicine guidelines on glycemic control for critically ill adults. Crit Care Med. 2026;54(8):2090-2101. https://doi.org/10.1097/CCM.0000000000007175
  • Gilbert BW, Zimmerman DE, Robertson A, Jones GD, Gendron BJ, Corio JL, Harlan SS, Engstrom K, Maisenbach A, Rambaran KA, Mercer KJ, Feldman R, Geier C, Truoccolo DS, Weant KA, et al. Role of the emergency medicine pharmacist in the management of boarding patients: an opinion of the emergency medicine practice and research network of the American College of Clinical Pharmacy endorsed by the SAEM Academy of Emergency Medicine Pharmacists and the Society of Emergency Medicine Pharmacists. J Am Coll Clin Pharm. 2026;9(6):e70227. https://doi.org/10.1002/jac5.70227
  • Griebe K, Smith ZR. Step VI: Expand your network. In: Parker RB, Enders SJ, eds. The ACCP Field Guide to Becoming a Standout Pharmacy Residency Candidate. 4th ed. American College of Clinical Pharmacy; 2026:123-139.
  • Fronrath M, Martz C, Griebe K, Veve M, Smith ZR. Comparison of safety and efficacy of cefepime administered via intravenous push versus intravenous piggyback infusion in patients with gram-negative bacteremia. J Clin Med. 2026;15(12):4768. https://doi.org/10.3390/jcm15124768
  • Frederick KD, Throneberry AR, Yett ES, Kodweis KR, Coleman CC, Hamilton LA, et al. Silos to synergy: developing collaborative scholarship theme teams for pharmacy faculty. Curr Pharm Teach Learn. 2026;18(7):102646. https://doi.org/10.1016/j.cptl.2026.102646
  • Heavner MS, Erdman G, Ziesat MC, et al. Gabapentin/pregabalin. In: Reinert JP, Branam DL, Veronin MA, et al, eds. Adjunctive Analgesic Strategies for the Bedside Clinician and Beyond: An Interdisciplinary Approach to Pain Management. Springer Nature; 2026.
  • Cordoza M, Kamdar BB, Gorecki N, Heavner MS. Promoting sleep in acute and critically ill adults: enhancing recovery through evidence-based practices. Crit Care Nurse. 2026;46(3):e1-e9. https://doi.org/10.4037/ccn2026191
  • Eng C, VanMeter E, Heavner MS. Polypharmacy and drug interactions in older patient. In: Pisani MA, ed. Aging and Lung Disease: A Clinical Guide. 2nd ed. Springer Nature; 2026.
  • Sacha GL, Heavner MS, Smith SE, Erstad BL. Neuromuscular blocking agents for acute respiratory distress syndrome: current controversies. Am J Health Syst Pharm. 2026 Jul 16. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxag220
  • Henry K, Murray B, Kamaleswaran R, Smith SE, Moore EG, Blotske K, Sikora A. Medication effects on heart rate variability in critical illness: the overlook confounder. Crit Care Explor. 2026;8(3):pe1386. https://doi.org/10.1097/CCE.0000000000001386
  • Chase AM, Almuntashiri S, Zhang D, Jones TW, Chen X, Somanath PR, Henry K, Sikora A. Predicting mortality with machine learning & biomarkers: a cohort analysis from aerosolized β2-agonist for treatment of acute lung injury (ALTA) trial. Physiol Rep. 2026;14(6):e70807. https://doi.org/10.14814/phy2.70807
  • Zhao B, Shen Y, Henry K, Devlin JW, Murphy DJ, Smith SE, Murray B, Rowe S, Sikora A. A data-driven medication regimen complexity score for critically ill patients: MRC-ICU 2.0. Pharmacotherapy. 2026;46(8):e70185. https://doi.org/10.1002/phar.70185
  • Govalan R, Hao S, Kenes MT, et al. Safety and effectiveness of phenobarbital vs. benzodiazepines for severe alcohol withdrawal in alcohol-associated liver disease in the ICU. JHEP Rep. 2026;8(4):101769. https://doi.org/10.1016/j.jhepr.2026.101769
  • Munroe ES, Walzl E, Seelye S, Cahill M, Czilok T, Jones J, Kenes MT, et al. Comorbidities, weight-based initial fluid resuscitation, and mortality in patients with sepsis. JAMA Netw Open. 2026;9(6):e2618232. https://doi.org/10.1001/jamanetworkopen.2026.18232
  • Barbee GA, Byrne BT, Clayton CE, Cole JH, Conklin CC, Donovan KA, Fisher AD, Gelfand HJ, Hughey SB, Hupfl KB, Hutchison CW, Keeley KJ, King JR, Kumar AJ, Lawrence KL, Littlejohn LF, Remley MA, Simmons SM, Wier RP, Wilson ZD, Yeager AP, Butler FK, et al. Analgesia in tactical combat casualty care (TCCC): TCCC Guideline Change 25-03. J Spec Oper Med. 2026;26(2):97-111. https://doi.org/10.55460/J.Spec.Oper.Med.2026.75L9-4KVD
  • Holder AL, Winterbottom F, Kosmisky DE, et al. The utility of automated, data-driven clinical support in telemedicine for critical illness: a survey-based study. Crit Care Explor. 2026;8(3):e1374. https://doi.org/10.1097/CCE.0000000000001374
  • Yang C, Eagers K, Kosmisky D, et al. Aripiprazole and unexpected salivation: a case of drug-induced sialorrhea refractory to anticholinergics. J Pharm Pract. 2026 Jun 29. [Epub ahead of print]. https://doi.org/10.1177/08971900261466364
  • Linn DD, Renew JR. Postoperative benefits of sugammadex: a narrative review. Am J Health Syst Pharm. 2026;83(5):e183-e191. https://doi.org/10.1093/ajhp/zxaf213
  • Linn DD, Renew JR, Brull SJ. Beyond the hype: understanding the limitations of sugammadex. Am J Health Syst Pharm. 2026;83(16):835-844. https://doi.org/10.1093/ajhp/zxag094
  • Renew JR, Linn DD, Logvinov II, et al. The impact of the “2023 American Society of Anesthesiologists practice guidelines for monitoring and antagonism of neuromuscular blockade” on quantitative neuromuscular monitoring two years later. Anesth Analg. 2026 Jun 25. [Epub ahead of print]. https://doi.org/10.1213/ANE.0000000000008190
  • Murray B, Bauer SR, Gao Y, Barreto E, Henry K, Blotske K, Sikora A. ABC’s of AI: proposing a clinician’s framework for the interpretation of artificial intelligence studies. Front Med. 2026;13:1787075. https://doi.org/10.3389/fmed.2026.1787075
  • O’Connell MB, Prescott GM, Allen M, Connor SE, Ford E, Formea CM, Gibson CM, Goodlet KJ, Jellinek-Cohen S, Mukherjee SM, Munir F, Nguyễn-Klatt JV, et al. From awareness to action: increasing health equity by addressing cultural and structural barriers in pharmacy practice, education, and research. J Am Coll Clin Pharm. 2026;9(4):e70206. https://doi.org/10.1002/jac5.70206
  • Olsen KM, Borchert J, Bookstaver PB, Chahine EB, Connor K, Cook AM, Dye M, Dull R, Hawkins WA, et al. Importance of residency training for the provision of comprehensive clinical pharmacy services. J Am Coll Clin Pharm. 2026;9(6):e70217. https://doi.org/10.1002/jac5.70217
  • Metts E, Carroll S, Posen A, Rech MA, Weant K. Medication safety strategies for geriatric patients in the emergency department: a narrative review. Acad Emerg Med. 2026;33(5):e70325. https://doi.org/10.1111/acem.70325
  • Rosewarne RE, Farina N. Thiamine use in hospitalized patients: a clinical review. J Nutr Metab. 2026;2026:7143046. https://doi.org/10.1155/jnme/7143046
  • Rosewarne RE, Perez S, Ingebrigtson M, Co I, McSparron J, Kenes M. SGLT2 inhibitor associated diabetic ketoacidosis in the intensive care unit. JAPhA Pharmacother. 2026 May 6. [Epub ahead of print]. https://doi.org/10.1016/j.japhar.2026.100033
  • Rosewarne RE, VanWert E. Crashing fast: evidence-based medication use in sympathetic crashing acute pulmonary edema. JEM Rep. 2026;5(2):100243. https://doi.org/10.1016/j.jemrpt.2026.100243
  • Rowe AS, Wiseman B, Hamilton LA, et al. Safety of tenecteplase in stroke mimics compared with acute ischemic stroke: a retrospective cohort study. Pharmacotherapy. 2026;46(1):e70112. https://doi.org/10.1002/phar.70112
  • Belden EB, Medenwald BL, Starnes CJ, Rowe AS, Christianson TJ, Farley KH, Minton KR, Hamilton LA. Optimizing levetiracetam dosage in status epilepticus: a retrospective cohort study. Neurologist. 2026;31(4):151-156. https://doi.org/10.1097/NRL.0000000000000673
  • Swanson A, Schwarz JS, Bektas AN, et al. Use of prucalopride in severe ileus in a critically ill patient with acute alcoholic hepatitis and hepatic encephalopathy. ACG Case Rep J. 2026;13(7):e02248. https://doi.org/10.14309/crj.0000000000002248
  • DiDomenico RJ, Smith SE, Chan A, Dougherty Z, Griebe K, Lee YR, Murray B, Roberts RJ, Shin ET, Vonderhaar JM, Weant KA. A roadmap for studying the impact of pharmacist board certification on patient outcomes: feasibility, applicability, and methodological considerations. J Am Coll Clin Pharm. 2026;9(2):e70165. https://doi.org/10.1002/jac5.70165
  • Smith SE, Henry K, Heavner MS, Keedy C, Duong H, Chen Z, Chen X, OPTIM Investigator Team, Sikora A. Impact of pharmacist board certification on health outcomes of critically ill patients: an analysis of the Optimizing Pharmacist-Team Integration for ICU patient Management (OPTIM) database. J Am Coll Clin Pharm. 2026;9(7):e70258. https://doi.org/10.1002/jac5.70258
  • Smith ZR, Kelly B, Wu S, et al. Pulmonary arterial hypertension: focused therapeutic update. Am J Health Syst Pharm. 2026 Apr 6. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxag102
  • Kabalka E, Smith Z, Tatem G, August B. Critically ill patients with severe cirrhosis receiving dexmedetomidine at a higher risk of cardiovascular instability: application of an objective novel cirrhosis scoring system. J Intensive Care Med. 2026;41(8):758-764. https://doi.org/10.1177/08850666251408751
  • Weant KA. Pharmacotherapy management of beta-blocker toxicity in the emergency department. Adv Emerg Nurs J. 2026;48(1):6-10. https://doi.org/10.1097/TME.0000000000000603
  • Wu TT, Jacobi J, Cullen C, O’Neil N, Vigorito J, Cavanaugh R, Devlin JW. Characterization of antidiabetic medication prescribing after hospital discharge in US critically ill adults. Ann Pharmacother. 2026 Jul 12. [Epub ahead of print]. https://doi.org/10.1177/10600280261455748

 Other Notable Achievements

  • Kaitlin Alexander: Fellow, American College of Critical Care Medicine.
  • Aeryana Bektas: Chair, SCCM CPP Membership Committee.
  • Scott Bolesta:
    • Co-Chair, Middle States Self-Study Steering Committee, Wilkes University.
    • Fellow, American Society of Health-System Pharmacists.
  • Donald Johnson: Fellow, American College of Critical Care Medicine.
  • Kevin Kaucher: Fellow, American College of Critical Care Medicine.
  • Melanie Madorsky: Fellow, American College of Critical Care Medicine.
  • Rowan Rosewarne: BCCCP.
  • Bethanie Shoulders: Fellow, American College of Critical Care Medicine.
  • Eric Wasowski: BCCCP.
  • Erin Wieurszewski: Fellow, American College of Critical Care Medicine.
  • Kimberly Won: Fellow, American College of Critical Care Medicine.

Drug Information PRN

Publications

  • Gilbert BW, Brown CS, Acquisto NM, et al. Consensus recommendations for clinical pharmacist integration into the acute stroke care team: endorsed by the American College of Clinical Pharmacy, Neurocritical Care Society, Society for Academic Emergency Medicine, and Society of Critical Care Medicine, and affirmed by the American Academy of Neurology. J Am Coll Clin Pharm. 2026;9(7):e70246. https://doi.org/10.1002/jac5.70246
  • Phillips J, Sarna K, Munir F, Ipema H. A comparative study of artificial intelligence and faculty rubric‑based grading of pharmacy student writing assignments in an evidence‑based medicine course. J Am Coll Clin Pharm. 2026;9(7):e70249. https://doi.org/10.1002/jac5.70249
  • Cain J, Thornby KA. Rest as strategy: the importance of psychological detachment from work for sustained career productivity. Am J Pharm Educ. 2026;90(8):102025. https://doi.org/10.1016/j.ajpe.2026.102025
  • Chen AMH, Rhoney DH, Thornby KA, et al. 2025-2026 Academic Affairs Committee report: advancing competency-based pharmacy education and academic coaching. Am J Pharm Educ. 2026;90(7):102009. https://doi.org/10.1016/j.ajpe.2026.102009
  • Rhoney DH, Chen AMH, Daugherty KK, Churchwell MD, Thornby KA, et al. Identifying stakeholder behaviors for competency-based pharmacy education: a stage 1 behavior change wheel analysis. Res Social Adm Pharm. 2026 Jun 18. [Epub ahead of print]. https://doi.org/10.1016/j.sapharm.2026.06.006

Presentations

  • Katie Kirby: ATTAIN MAINTAIN trial. Presented at: ACCP Drug Information PRN Virtual Journal Club; July 2026; virtual.
  • Braidon Lape: COBRRA trial. Presented at: ACCP Drug Information PRN Virtual Journal Club; May 2026; virtual.
  • Caitlyn Lucore: FINE‑ARTS‑HF study. Presented at: ACCP Drug Information PRN Virtual Journal Club; August 2026; virtual.
  • Faria Munir, Sally Arif: Combating medical misinformation in the age of generative AI: health equity lens. Presented at: ACCP Drug Information PRN and Health Equity PRN CE Programming Committee Webinar; August 2026; virtual. Moderator: Maha Abdalla. Cross-PRN CE committee members: Maha Abdalla, Julie Sibbesen, Daphne Smith Marsh, Genevieve L. Engle, Sharon E. Connor.

Other Notable Achievements

  • Caitlin S. Brown: Incoming Drug Information PRN Secretary/Treasurer.
  • Genevieve L. Engle: Incoming Drug Information PRN Chair-Elect.

Education and Training PRN

Promotions

  • Mariann Churchwell: Professor Emerita, University of Toledo.
  • Logan Franck: Clinical Associate Professor, University of Nebraska Medical Center.
  • Anthony Hawkins: Clinical Professor, University of Georgia College of Pharmacy.
  • Denise Kolanczyk: Professor of Pharmacy Practice, Midwestern University College of Pharmacy – Downers Grove, IL Campus.
  • Rachel Lucas: Clinical Associate Professor – Binghamton University School of Pharmacy and Pharmaceutical Sciences.
  • Julie A. Murphy: Professor and Associate Dean of Academic Affairs, The University of Toledo.
  • Jarred Prudencio: Professor, Pharmacy Practice, University of Hawaii at Hilo.
  • Taylor Steuber: Clinical Professor, UMKC School of Pharmacy.
  • Andrew Stone: Senior Specialty Practice Pharmacist, The Ohio State University Wexner Medical Center James Comprehensive Cancer Center.
  • Sarah Thompson: Clinical Assistant Faculty, University of Georgia College of Pharmacy.

Awards

  • Snehal Bhatt: Inaugural Center for Teaching and Learning Fellow, The Massachusetts College of Pharmacy and Health Sciences.
  • Paul Boylan: Provost’s Teaching Award – Early Career Faculty, The University of Oklahoma Health Campus.
  • Chen A, Thornby K, Law A. Curriculum Special Interest Group (SIG) 2025 Publication Award. AACP. July 2026.
  • Kate Cozart: Tennessee Pharmacists Association Student Advocate Award.
  • Rachel Lucas:
    • Dean’s Award for Faculty Teaching Innovation 2025, Binghamton University SOPPS.
    • New Practitioner Award, New York State Council of Health-System Pharmacists (NYSCHP).
  • Marina Maes: P3 Teacher of the Year, University of Wisconsin-Madison.
  • Mate Soric:
    • Olson/Blair Award for Administrative Excellence, Northeast Ohio Medical University.
    • Commencement Hooder, Class of 2026, Northeast Ohio Medical University.
  • Andy Stone: Preceptor of the Year; The Ohio State University College of Pharmacy Doctor of Pharmacy Class of 2026.
  • Sarah Thompson: Creative Teaching in Pharmacy Award, University of Georgia College of Pharmacy.

Grants

  • Bach K, Lucas RC. Patient Education and Interprofessional Education Facilitated Through Service Learning in Community Pharmacies. Binghamton University Center for Civic Engagement (CCE) ($2000).

Publications

  • Albanese NP. Systemic lupus erythematosus. In: Koehler JM, Borchert JS, Slain DS, et al, eds. Schwinghammer’s Pharmacotherapy Casebook: A Patient-Focused Approach. 13th ed. McGraw-Hill; 2026.
  • Olsen KM, Borchert JS, Bookstaver PB, Chahine EB, Connor KA, Cook AM, Dye M, Dull R, Hawkins WA, Adams KK, Doloresco F, Hamada H, Hollis I, et al. Importance of residency training for the provision of comprehensive clinical pharmacy services. J Am Coll Clin Pharm. 2026;9(6):e70217. https://doi.org/10.1002/jac5.70217
  • Boylan PM. K-type questions and the MPJE: recommendations for evidence-based item reform. Curr Pharm Teach Learn. 2026;18(10):102672. https://doi.org/10.1016/j.cptl.2026.102672
  • Bennett A, Murray B, Sikora A, Reynolds E, Branan TN, Bland CM, Hawkins WA, Smith SE. The weight debate: ideal versus total body weight for fluid resuscitation in septic shock. Am J Health Syst Pharm. 2026;83(5):e220-e226. https://doi.org/10.1093/ajhp/zxaf313
  • Chen AMH, Rhoney DH, Thornby KA, Chung EP, Churchwell MD, Coyle EA, Daugherty KK, Elmes-Patel A, Kleppinger EL, Maldonado Davila WT, Minze M, Nelson NR, Rapier M, Shehata M, Sibicky SL, Traynor A, Ragucci KR, et al. 2025-2026 Academic Affairs Committee report: Advancing competency-based pharmacy education and academic coaching. Am J Pharm Educ. 2026;90(7):102009. https://doi.org/10.1016/j.ajpe.2026.102009
  • Dudley RW, Lewis SJ, Churchwell MD, et al. Evaluating the compatibility, stability, and antimicrobial effectiveness of vancomycin and cefepime admixtures in peritoneal dialysis solutions. Sci Rep. 2026;16(1):22891. https://doi.org/10.1038/s41598-026-53865-x
  • Cozart K. A prescription for hope. In: Nolen A, Ivey MF, Walker PC, et al, eds. Spirituality in Pharmacy Practice: Perspectives on Whole-Person Care. American Society of Health-System Pharmacists; 2026.
  • Churchwell MD, Reinert JP. Clinically significant drug-drug interactions. In: Reinert JP, Branam DL, Veronin MA, et al, eds. Adjunctive Analgesic Strategies for the Bedside Clinician and Beyond: An Interdisciplinary Approach to Pain Management. 1st ed. Springer; 2026:229-243.
  • Lewis SJ, Sjoquist L, Churchwell MD. Management of adverse drug effects for adjunctive analgesics. In: Reinert JP, Branam DL, Veronin MA, et al, eds. Adjunctive Analgesic Strategies for the Bedside Clinician and Beyond: An Interdisciplinary Approach to Pain Management. 1st ed. Springer; 2026:205-227.
  • Sowinski KM, Churchwell MD. Hemodialysis and peritoneal dialysis. In: Haines ST, Nolin TD, Ellingrod VL, et al, eds. DiPiro’s Pharmacotherapy: A Pathophysiologic Approach. 13th ed. McGraw Hill; 2026.
  • Foote DC, Matthews DE, Li J, et al. Simulated live interpreter-patient encounters: impact on pharmacy students’ communication skills and confidence. Am J Pharm Educ. 2026;90(9):102037.
  • Cheng Y, Gaborcik JW, Stone AC. Insulin glargine use in dexamethasone-induced hyperglycemia: a retrospective cohort analysis. Ann Pharmacother. 2026 Jul 8. [Epub ahead of print]. https://doi.org/10.1177/10600280261457153
  • Forehand CC, Benken ST, Madorsky M, Mohamed A, Nguyễn JV, Dixit D, Gallagher J, Hawkins WA, Heavner MS, Johnson E, Lozano L, Sisco M, Slampak-Cindric AA, Smith SE, Spezzano K, Taylor BA 2nd, et al. Pharmacotherapeutic controversies during temperature control after out-of-hospital cardiac arrest: a semi-structured literature review. Pharmacotherapy. 2026;46(1):e70095. https://doi.org/10.1002/phar.70095
  • Tillman-Nelson PS, Hawkins WA. Comment on “Preparing future pharmacists for an AI-enhanced health care environment: educational strategies and implementation challenges.” J Am Coll Clin Pharm. 2026;9(5):e70212. https://doi.org/10.1002/jac5.70212
  • Chambers JY, Janzen KM, Boulton A. Midnight medicine: empowering night shift to treat opioid use disorder (OUD). J Opioid Manag. 2026;22(2):129-133. https://doi.org/10.5055/jom.0993
  • Pulliam H, Gorostiza I, Jeon M, et al. Impact of specifications grading on a pharmacy communication and professionalism course. Curr Pharm Teach Learn. 2026;18(11):102731. https://doi.org/10.1016/j.cptl.2026.102731
  • Nasuhidehnavi A, Lucas RC, Bach K, et al. Etripamil: the first FDA-approved intranasal L-type calcium channel blocker for acute termination of paroxysmal supraventricular tachycardia. Ann Pharmacother. 2026 Jul 8. [Epub ahead of print]. https://doi.org/10.1177/10600280261454696
  • McGiness TM, Finch C. Asthma and chronic obstructive pulmonary disease. In: The APhA Complete Review for Pharmacy. 14th ed. American Pharmacists Association; 2026.
  • Mihm AE, Wingler AJ, Owen MP, Anderson ER. Evaluation of inhaler prescribing trends in hospitalized patients with suspected but unconfirmed chronic obstructive pulmonary disease. J Pharm Technol. 2026 Jun 29. [Epub ahead of print]. https://doi.org/10.1177/87551225261454868
  • Murphy JA, Maktabi L, Matus C. Anticonvulsants. In: Reinert JP, Branam DL, Veronin MA, et al, eds. Adjunctive Analgesic Strategies for the Bedside Clinician and Beyond: An Interdisciplinary Approach to Pain Management. Springer Nature; 2026.
  • Nelson NR, Chen AMH, Yu F, Carlson R, Thornby KA, Daugherty KK, Chung EP, Churchwell MD, Sibicky SL, Kleppinger EL, Parker D, Ragucci KR, Stowe CD, Brock TP, Rhoney DH. A bibliometric analysis describing the global scope of pharmacist roles (2000-2024). J Am Pharm Assoc (2003). 2026;66(5):103470. https://doi.org/10.1016/j.japh.2026.103470
  • Passalacqua MR, Knefelkamp CA, Kniery KZ, et al. Outcomes from the use of cefazolin for surgical prophylaxis in penicillin allergic patients. Fed Pract. 2026;43(3):100-104. https://doi.org/10.12788/fp.0675
  • Rhoney DH, Chen AMH, Daugherty KK, Churchwell MD, Thornby KA, Nelson NR, Kleppinger EL, Parker D, Sibicky SL, Brock T, Stowe CD, Ragucci KR. Identifying stakeholder behaviors for competency-based pharmacy education: a stage 1 behavior change wheel analysis. Res Social Adm Pharm. 2026 Jun 18. [Epub ahead of print]. https://doi.org/10.1016/j.sapharm.2026.06.006
  • Rhoney DH, Chen AMH, Thornby KA, Nelson NR, Daugherty KK, Churchwell MD, Kleppinger EL, Sibicky SL, Parker D Jr, Ragucci KR, et al. Future-proofing pharmacy: a stakeholder-informed forecast of workforce and education needs. J Am Coll Clin Pharm. 2026;9(2):e70177. https://doi.org/10.1002/jac5.70177
  • Rhoney DH, Daugherty KK, Chen AMH, et al. A unifying vision for pharmacy: defining professional identity through stakeholder perspectives. J Am Pharm Assoc. 2026;66(2):103013. https://doi.org/10.1016/j.japh.2025.103013
  • Ruehman AJ, Covington E, Branan TN, Hawkins WA, Smith SE. Current practices and opinions related to hemodynamic optimization in patients with sepsis: an international survey. Am J Crit Care. 2026;35(3):191-198. https://doi.org/10.4037/ajcc2026584
  • Stropes A, Lautenschlager C, Smith AJ, Steuber TD, et al. Linezolid versus clindamycin for toxin inhibition in severe skin and soft tissue infections: a systematic review and meta-analysis. Infection. 202654(2):877-885. https://doi.org/10.1007/s15010-025-02722-6
  • Skory B, Arko J, Terkawi L, Slusarz E, King O, Deokarran C, Glista K, Will M, Etemadi H, Brosch E, Wasowski E, Soric MM. Prevalence of beta blocker prescribing for hypertension. J Pharm Technol. 2026;42(3):115-122. https://doi.org/10.1177/87551225261417534
  • Vergara M, Soric MM, King O, Bullock R, Skory B, Bole K, et al. Prescribing patterns of gabapentinoids in patients with chronic obstructive pulmonary disorder. COPD. 2026;23(1):2596683. https://doi.org/10.1080/15412555.2025.2596683
  • Steuber CO, Bowers BL, Englin EF, Moreno NM, Campbell AR, Cillessen L, Salvatore D, Steuber TD. Impact of a blinded journal club on student pharmacist knowledge and retention. Curr Pharm Teach Learn. 2026;18(9):102690. https://doi.org/10.1016/j.cptl.2026.102690
  • Steuber TD, Belk M, Thayer B, et al. Nirmatrelvir-ritonavir versus short-course remdesivir for mild COVID-19 in high-risk hospitalized patients: a propensity score-matched study. J Pharm Technol. 2026;42(4):181-186. https://doi.org/10.1177/87551225261436716
  • Thayer B, Reese MK, Nelson TB, Bran AA, Steuber TD. Building a culture of stewardship: the role of infectious diseases pharmacists in promoting documentation across pharmacy teams. J Am Coll Clin Pharm. 2026;9(4):e70203. https://doi.org/10.1002/jac5.70203
  • Cain J, Thornby KA. Rethinking success to reduce work-life tensions. Am J Pharm Educ. 2026;90(4):101975. https://doi.org/10.1016/j.ajpe.2026.101975
  • Cain J, Thornby KA. Rest as strategy: the importance of psychological detachment from work for sustained career productivity. Am J Pharm Educ. 2026;90(8):102025. https://doi.org/10.1016/j.ajpe.2026.102025
  • Tran BAC, Miller T. Hypomagnesemia from malabsorption and renal magnesium wasting treated with high-dose magnesium glycinate: a case report. J Am Pharm Assoc. 2026 Aug 7. [Epub ahead of print]. https://doi.org/10.1016/j.japh.2026.103496

Presentations

  • Buatois E. Hidden in plain sight: how thread champions weave curricular threads to strengthen the PharmD fabric. Presented at: American Association of Colleges of Pharmacy (AACP) Annual Meeting; July 2026; Grapevine, TX.
  • Chen A, Thornby K, Nelson N, Rhoney D. The system teaches what it rewards: what if our assessment culture is the curriculum? Presented at: AACP Annual Meeting; July 2026; Dallas, TX.
  • Cozart K. Confidence in care: supporting Gen Z learners to overcome impostor phenomenon in the patient care setting. Presented at: American Society of Health-System Pharmacists (ASHP) Live Webinar; May 2026; virtual.
  • Foote D. Pressure points: navigating the 2025 hypertension guideline updates. Presented at: Ohio Pharmacists Association Annual Conference; April 2026; Columbus, OH.
  • Janzen KM. Too many hats: strategically sharing the service load. Presented at: AACP Annual Meeting; July 2026; Grapevine, TX.
  • Knock M, Elmes-Patel A. Hitting the right notes: harmonizing entrustment-supervision scales in pharmacy education. Presented at: AACP Annual Meeting; July 2026; Grapevine, TX.
  • McGiness T. New frontiers in hyperkalemia care: the role of managed care professionals and novel potassium binders. Presented at: Academy of Managed Care Pharmacy (AMCP) Annual Meeting; March 2026; Nashville, TN.
  • Minze M, Elmes-Patel A. Same goal, different game: advising versus coaching. Presented at: AACP Annual Meeting; July 2026; Grapevine, TX.
  • Passalacqua MR. Changing the paradigm: buprenorphine for chronic pain. Presented at: Indiana Pharmacy Association Annual Meeting; March 2026; Carmel, IN.
  • Thornby K. Teaching and assessing drug information and literature evaluation competencies for modern learners. Presented at: AACP Drug Information and Library Sciences Webinar Session; May 2026; virtual.
  • Tran BA. Using AI in everyday workflows: practical, human-centered applications. Presented at: AACP Technology in Pharmacy Education and Practice Special Interest Group (SIG); May 2026; virtual.
  • Wettergreen SA, Stewart MP, Janzen KM. Know thyself: turning accountability styles into productivity power. Presented at: AACP Annual Meeting; July 2026; Grapevine, TX.
  • Woodruff AE, Albanese NP. From coddling to capability: reframing student support for resilience and wellbeing. Presented at: AACP Annual Meeting; July 2026; Grapevine, TX.

Other Notable Achievements

  • Snehal Bhatt: Fellow of the American College of Cardiology.
  • Paul Boylan: MS degree in Clinical and Translational Science from The University of Oklahoma Graduate College, Norman, OK.
  • Kate Cozart: Fellow of the Tennessee Pharmacists Association.
  • Beth H. Resman-Targoff:
    • Coauthored a course for the American College of Rheumatology/Association of Rheumatology Professionals: A5: Advances in Pharmacologic Management of Rheumatic Conditions.
    • Coauthored an Advanced Rheumatology Course (ARC), American College of Rheumatology/Association of Rheumatology Professionals, July 2026.

Emergency Medicine PRN

Promotions

  • Jerika Nguyễn-Klatt: Clinical Pharmacy Specialist, Emergency Medicine, Trinity Health Grand Rapids, Grand Rapids, MI.
  • Alyssa Robertson: Clinical Pharmacy Manager, UPMC Harrisburg, Harrisburg, PA.
  • David Zimmerman: Professor with Tenure, Duquesne University, Pittsburgh, PA.

Awards

  • Alyssa Robertson: Golden Apple Educator Award, WellSpan Health.

Grants

  • Jerika Nguyễn-Klatt: ACCP Critical Care PRN Multicenter Research Grant.
  • Megan Rech: 2026-2027 Polypharmacy Clinical Decision Support Tool Evaluation, VA Quality Enhancement Research Initiative (QUERI), Department of Veterans Affairs.

Publications

  • Acquisto NM, Smith AP, Harrington AT, Santarossa M, Adams J, Rech MA. Rapid diagnostic testing of gonorrhea and chlamydia improves antimicrobial stewardship in the emergency department. Am J Emerg Med. 2026 Jul 22. [Epub ahead of print]. https://doi.org/10.1016/j.ajem.2026.07.034
  • Gilbert BW, Brown CS, Acquisto NM, Engstrom KK, Mercer KJ, Howington GT, Zimmerman DE, Gottlieb M, Mattson AE, Rech MA, Wieruszewski ED, Webb AJ, Faine B, Ray LC, et al. Consensus recommendations for clinical pharmacist integration into the acute stroke care team: endorsed by the American College of Clinical Pharmacy, Neurocritical Care Society, Society for Academic Emergency Medicine, and Society of Critical Care Medicine, and affirmed by the American Academy of Neurology. J Am Coll Clin Pharm. 2026;9(7):e70246. https://doi.org/10.1002/jac5.70246
  • Gilbert BW, Zimmerman DE, Robertson A, Jones GD, Gendron BJ, Corio JL, Harlan SS, Engstrom K, Maisenbach A, Rambaran KA, Mercer KJ, Feldman R, Geier C, Truoccolo DS, Weant KA, et al. Role of the emergency medicine pharmacist in the management of boarding patients: an opinion of the Emergency Medicine Practice and Research Network of the American College of Clinical Pharmacy endorsed by the SAEM Academy of Emergency Medicine Pharmacists and the Society of Emergency Medicine Pharmacists. J Am Coll Clin Pharm. 2026;9(6):e70227. https://doi.org/10.1002/jac5.70227
  • Lawson C, Rech MA, Sun J, Celmins L, Sindelar M, Van Wert E, Fletcher AA, Coralic Z, Zimmerman DE, Howington GT, Woolum JA, Krenz J, Mattson AE, Brown CS, et al. A multi-center retrospective cohort study of SUGAmmadex for neuromuscular blockade reversal in the emergency department: SUGARED study. Am J Emerg Med. 2026;109:27-34. https://doi.org/10.1016/j.ajem.2026.06.021
  • Mercer KJ, Sterr JL. Laughing gas, serious consequences: recognizing nitrous oxide toxicity in the emergency department. Emerg Med News. 2026;48(4):16-17. https://doi.org/10.1097/01.EEM.0000000000000215
  • Metts E, Carroll S, Posen A, Rech MA, Weant K. Medication safety strategies for geriatric patients in the emergency department: a narrative review. Acad Emerg Med. 2026;33(5):e70325. https://doi.org/10.1111/acem.70325
  • O’Connell MB, Prescott GM, Allen M, Connor SE, Ford E, Formea CM, Gibson CM, Goodlet KJ, Jellinek-Cohen S, Mukherjee SM, Munir F, Nguyễn-Klatt JV, et al. From awareness to action: increasing health equity by addressing cultural and structural barriers in pharmacy practice, education, and research. J Am Coll Clin Pharm. 2026;9(4):e70206. https://doi.org/10.1002/jac5.70206
  • Fletcher M, Patek T, Wiley C, Sarangarm P, et al. Stability of naloxone in normal saline for continuous infusion. Int J Pharm Compd. 2026;30(3):287-294.
  • Ray L, Gottlieb M, Long B, Riscinti M, Rech MA. Regional anesthesia in the emergency department: a review of key pharmacotherapeutic considerations. Am J Emerg Med. 2026;105:63-72. https://doi.org/10.1016/j.ajem.2026.04.003
  • Rech MA, DeWitt K, Ray LC. Closing the gaps in hyperacute stroke care: pharmacologic and systems-level considerations. Am J Emerg Med. 2026;108:267-268. https://doi.org/10.1016/j.ajem.2026.06.005
  • Rech MA, Gottlieb M. Thrombolytics can be used in selected patients with acute ischemic stroke taking factor Xa inhibitors. Ann Emerg Med. 2026;87(4):486-487. https://doi.org/10.1016/j.annemergmed.2025.06.614
  • Rech MA, Gottlieb M. Cephalosporins should be the preferred oral antibiotics for empiric treatment of outpatient acute pyelonephritis. Ann Emerg Med. 2026;88(2):223-224. https://doi.org/10.1016/j.annemergmed.2025.12.003
  • Rech MA, Gottlieb M. Norepinephrine should be the preferred vasopressor after return of spontaneous circulation following cardiac arrest. Ann Emerg Med. 2026;87(3):342-343. https://doi.org/10.1016/j.annemergmed.2025.09.028
  • Rech MA, Howington GT. The pharmacy profession’s public relations problem: visibility, value, and voice. J Am Coll Clin Pharm. 2026;9(8):e70261. https://doi.org/10.1002/jac5.70261
  • Rech MA, Zimmerman DE, Howington GT, Mercer KJ, et al; on behalf of EMPHARM-NET Investigators. Forming & maintaining a research network: Emergency Medicine Pharmacotherapy Research Network (EMPHARM-NET). Am J Emerg Med. 2026;104:74-78. https://doi.org/10.1016/j.ajem.2026.03.001
  • Rech MA, Zimmerman DE, Ray L, Desai D, Hoffman JW, Howington GT. Diagnosis and management of acute hyperkalaemia. BMJ. 2026. [In press]
  • Berger K, Webb AJ, Rabon AD, Celmins LE, Lovett S, Cuker A, Dixon A, Rech MA. Expert opinion on implementing oral anticoagulation reversal protocols in US hospitals. Clin Appl Thromb Hemost. 2026 Apr 20. [Epub ahead of print]. https://doi.org/10.1177/10760296261442058
  • Dumont Z, Rogers KC, Alhammad AM, Coons JC, Dager WE, Edwards ME, Higgins T, Miesner AR, Pon T, Rech MA, et al. Value of inpatient clinical pharmacists. J Am Coll Clin Pharm. 2026;9(6):e70230. https://doi.org/10.1002/jac5.70230
  • Htet NN, Walker JA, Jafari D, Rech MA, et al. The authors respond to reader comment regarding “Outcomes of boarding critically ill patients in U.S. EDs: a systematic review and meta-analysis.” Am J Emerg Med. 2026;103:203-204. https://doi.org/10.1016/j.ajem.2026.02.019
  • Kiskaddon AL, Johnson PN, Dallas L, Stang C, Beckman E, Gattis S, Smith C, Pingle J, Butchin J, Ordons KJ, Amankwah EK, Witt DM, Rech MA, et al. Pharmacist antithrombotic interventions in critically ill children: a multicenter prospective study. Am J Health Syst Pharm. 2026 May 18. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxag117
  • Long B, Rech MA, Gottlieb M. In reply. Ann Emerg Med. 2026;88(1):119-120. https://doi.org/10.1016/j.annemergmed.2026.02.017
  • Yarlagadda S, Huang L, Dharanipragada D, Younan M, Arshad A, Paniagua-Perez D, Rech MA, et al. High-dose opioid use among adolescents and young adults with chronic digestive disorders. Dig Dis Sci. 2026 Mar 26. [Epub ahead of print]. https://doi.org/10.1007/s10620-026-09853-2
  • Wang Y, Ades R, Wu M, Ma B, Allen R, Stonewall H, et al. Using social exchange theory to explore motivational matching between experiential programs and preceptors. Am J Pharm Educ. 2026;90(5):101977. https://doi.org/10.1016/j.ajpe.2026.101977
  • Zimmerman DE, Goodstein D, Durney PA 3rd, et al. Presentation and management of acute medetomidine withdrawal. Am J Health Syst Pharm. 2026 May 5. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxag141

Other Notable Achievements

  • Elise Metts: BCEMP.
  • Jerika Nguyễn-Klatt:
    • SCCM MI Chapter Secretary.
    • ACCP Health Equity PRN Chair-Elect.
  • Megan Rech: Past President, Academy of Emergency Medicine Pharmacists (AEMP).
  • Alyssa Robertson: MEd degree.
  • Christina Tran:
    • SAEM Programming Committee Volunteer Subcommittee Co-Chair (2026-2027).
    • AEMP Programming Committee Co-Chair (2026-2027).
  • Kyle Weant: Research Committee Chair, Academy of Emergency Medicine Pharmacists (AEMP).
  • Sarah Steely Wright: BCEMP.

Endocrine and Metabolism PRN

Promotions

  • Ashlyn Aguiniga: Associate Professor, Department of Pharmacotherapy, University of North Texas System College of Pharmacy and Health Professions.
  • Laura Challen: Professor, Department of Pharmacy Practice, University of Health Sciences & Pharmacy in St. Louis.
  • Ben Gross: Professor, Department of Pharmacy and Pharmaceutical Sciences, Lipscomb University College of Pharmacy.
  • Sara Lingow: Associate Professor, Department of Pharmacy Practice, University of Health Sciences & Pharmacy in St. Louis.
  • Liz Van Dril: Clinical Associate Professor, University of Illinois Chicago Retzky College of Pharmacy.

Awards

  • Lauren Cunningham: 2026 ACCP Ambulatory Care PRN MeRIT Scholarship.
  • Ben Gross: 2026 Faculty of the Year selected by 2028 Pharmacy Class, Lipscomb University College of Pharmacy.
  • Diana Isaacs: American Diabetes Association Outstanding Educator in Diabetes.

Publications

  • Harringfeld S, Cunningham L, Van Dril L. Pharmacist intervention for safer prescribing in patients with type 2 diabetes at high risk: a randomized clinical trial [comment]. JAMA Netw Open. 2026;9(2):e2559946. https://doi.org/10.1001/jamanetworkopen.2025.59946
  • Isaacs D, Kruger D, Cornell S, et al. Pen needle reuse in people with diabetes who inject insulin: a narrative review. Diabetes Ther. 2026 Jul 16. [Epub ahead of print]. https://doi.org/10.1007/s13300-026-01900-5
  • Lansang MC, Malloy K, Knapp S, Veeramachaneni R, Rahhal MN, Arce KM, Mucci A, Zhou K, Isaacs D. Insulin pump guide for health care professionals: settings, interpretation, and adjustment. Endocr Pract. 2026;32(4):651-664. https://doi.org/10.1016/j.eprac.2025.12.025
  • Min E, Goyette A, Young E, Moon K, Bellini N, Isaacs DM. Incretins for type 2 diabetes. Can J Physiol Pharmacol. 2026 Jun 6. [Epub ahead of print]. https://doi.org/10.1139/cjpp-2025-0142
  • Lennon A. Management of overweight and obesity. In: Irons BK, Meredith AH, eds. Ambulatory Care Self-Assessment Program, 2026. ACSAP 2026. American College of Clinical Pharmacy, 2026:133-161.
  • Pervanas HC, Mukherjee SM, Silva M. Self-regulated learning behavior clusters associated with NAPLEX readiness exam performance during advanced pharmacy practice experiences. Am J Pharm Educ. 2026;90(10):102050. https://doi.org/10.1016/j.ajpe.2026.102050
  • Van Dril E, Schumacher CA. Diabetic kidney disease. In: Cornell S, Miller DK, Urbanski P, eds. The Art and Science of Diabetes Care and Education. 7th ed. Association of Diabetes Care and Education Specialists; 2026:791-822.
  • Landup D, Hanners Dunn E, Van Dril E, et al. The cost conundrum: pharmacists at the crossroads of evidence and affordability. J Am Coll Clin Pharm. 2026;9(2):e70181. https://doi.org/10.1002/jac5.70181
  • Salama S, Bolch C, Landup D, Van Dril E, Schumacher C. Factors that influence blood pressure changes with the use of sodium-glucose cotransporter 2 inhibitors in people with type 2 diabetes. Pharmacotherapy. 2026;46(6):e70156. https://doi.org/10.1002/phar.70156

Presentations

  • Ashlyn Aguiniga. From pancreas to powerhouse: GLP-1 evolution beyond diabetes. Presented at: Texas Society of Health-System Pharmacists Annual Seminar; April 2026; Galveston, TX.
  • Nicole Albanese:
    • Alternate pathways into pharmacy: a multi-institutional study of student satisfaction and career intentions. Presented at: American Association of Colleges of Pharmacy Annual Meeting; July 2026; Grapevine, TX.
    • From coddling to capability: reframing student support for resilience and wellbeing. Presented at: American Association of Colleges of Pharmacy Annual Meeting; July 2026; Grapevine, TX.
  • Lauren Cunningham:
    • Module 11: Ambulatory care roles in diabetes, subsection: application of population health data. Presented at: American Society of Health-System Pharmacists Diabetes Management Certificate; May 2026; virtual.
    • Module 11: Ambulatory care roles in diabetes, subsection: population health. Presented at: American Society of Health-System Pharmacists Diabetes Management Certificate; May 2026; virtual.
  • Lauren Cunningham and Liz Van Dril: Bean there, done that: optimizing kidney health in people with diabetes. Presented at: Association of Diabetes Care and Education Specialists Annual Meeting; August 2026; Columbus OH.
  • Harrigfeld S, Cunningham L, Layden B, Muppuru B, Silva K, Smith Marsh D, Stepping C, Van Dril E, et al. Screening rates and guideline-directed medical therapy use for chronic kidney disease in people with type 2 diabetes. Presented at: American Diabetes Association 86th Scientific Sessions Poster Session; June 2026; New Orleans, LA.
  • Abby Lennon: The weight is over: new guidelines for obesity management. Presented at: Virginia Society of Health-System Pharmacists Spring Seminar; March 2026; Williamsburg, VA.
  • Christie Schumacher:
    • Guidelines for non-insulin medication management in patients with type 2 diabetes. Presented at: Association of Diabetes Care and Education Specialists Live Webinar; February 2026; virtual.
    • Integrated care: diabetes guideline updates and the cardio-kidney-metabolic (CKM) syndrome. Presented at: CEImpact continuing education program; February 2026; virtual.
  • Daphne Smith Marsh:
    • Bridging cultures and clinical care: navigating diabetes management in diverse dietary and fasting traditions. Presented at: Illinois Council of Health-System Pharmacists Spring Meeting; March 2026; Springfield, IL.
    • Equity in diabetes care: the clinical pharmacist impact. Presented at: NPhA/SNPhA Annual Conference; August 2026; Rockville, MD.
    • Exploring cultural humility in student pharmacists. Presented at: American Association of Colleges of Pharmacy Annual Meeting; July 2026; Grapevine, TX.
  • Liz Van Dril:
    • Module 4: Billing and reimbursement methods and opportunities for pharmacist patient care clinical services. Presented at: American Society of Health-System Pharmacists Billing and Reimbursement for Patient Care Clinical Services Certificate; June 2026; virtual.
    • Module 6: Diabetes treatment for patients with cardiovascular and renal disease. Presented at: American Society of Health-System Pharmacists Diabetes Management Certificate; May 2026; virtual.

New ACCP Fellows

  • Kylee Funk
  • Regina Ginzburg
  • Rick Hess
  • Ashley M. Higbea
  • Sumana M. Mukherjee
  • Jordan Rowe
  • Elizabeth K. Van Dril

Other Notable Achievements

  • Diana Isaacs: Appointed to American Association of Clinical Endocrinology Board of Directors.

Geriatrics PRN

Promotions

  • Emily Christenberry: Director, Pharmaceutical Clinical Services, University Medical Center of El Paso.

Awards

  • Haowen Hsu: PhRMA Foundation Trainee Challenge Award, PhRMA Foundation and Journal of Managed Care & Specialty Pharmacy.
  • Barbara Zarowitz: Fellow of the Society for Post-acute and Long-term Care Medicine – 2026. Post-Acute and Long-term Care Medicine (PALTmed).

Grants

  • Haowen Hsu: Developing an AI Agent to Support Post-Discharge Care Among Older African American Adults with Multiple Chronic Conditions. Community Health Equity Pilot Studies Program. University at Buffalo Community Health Equity Research Institute and National Institute on Minority Health and Health Disparities (NIMHD) Center for Excellence [Award Number 1P50MD019473], “Igniting Hope in Buffalo NY Communities: Training the Next Generation of Public Health Researchers.” Principal Investigator ($67,500).

Publications

  • Hsu H, Clark CM, Feuerstein S, et al. Trends and expenditures in polypharmacy and hyperpolypharmacy among older adults in the United States, 2002-2017. BMC Geriatr. 2026;26(1):515. https://doi.org/10.1186/s12877-026-07172-9
  • Hsu H, Clark CM, Feuerstein S, et al. Cognitive potentially inappropriate medications, quality of life, and healthcare use in older adults with cognitive disorders. J Am Geriatr Soc. 2026 Aug 4. [Epub ahead of print]. https://doi.org/10.1111/jgs.70607
  • Hsu H, Gazetta G, Lu CH, et al. An ontology-informed framework to harmonize EHR medication data for managed care analytics and AI applications. J Manag Care Spec Pharm. [In press]
  • Tarun AI, Hsu H, Clark CM, et al. Pharmacist-led social needs and medication history intervention in the emergency department: a feasibility pilot study. J Am Pharm Assoc (2003). 2026;66(5):103483. https://doi.org/10.1016/j.japh.2026.103483
  • Lisi DM. AI and pharmacogenomics use to assess infection risk in cancer patients. US Pharm. 2026.
  • Walter J, Bateman MT, Giaquinto A, Greer D, Liu M, Mansukhani R, O’Kane C, et al. A survey exploring perceptions and influences of professional dress in the profession of pharmacy. Pharm Educ. 2026;26(1):255-268. https://doi.org/10.46542/pe.2026.261.255268
  • Zarowitz BJ, Apple B, Newcomb L, et al. You need an age-friendly pharmacist. Caring for the Ages. 2026 July.
  • Zarowitz BJ, Francis E, Thomas A, et al. Years in practice, differences in perspectives: survey findings from age-friendly pharmacists. J Am Coll Clin Pharm. 2026;9(7):e70244. http://dx.doi.org/10.1002/jac5.70244
  • Zarowitz BJ, Little M, Vaughan W, et al. Leveraging pharmacists using RE-AIM framework to implement age-friendly nursing home care. J Am Med Dir Assoc. 2026;27(6):106206. https://doi.org/10.1016/j.jamda.2026.106206
  • Zarowitz BJ, Semla T, Van C, et al. Comment on “Adopting race‐free estimated glomerular filtration rate for unifying medication‐related decision‐making: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy” [letter]. J Am Coll Clin Pharm. 2026;9(2):e70179. http://dx.doi.org/10.1002/jac5.70179
  • Zarowitz BJ, Van C, Semla T. The NKF has spoken: now what’s a clinician to do? J Am Geriatr Soc. 2026;74(4):1213-1217. http://doi.org/10.1111/jgs.70280
  • Van C, Zarowitz BJ, Meier A, et al. An innovative, GIS-based approach in expanding age-friendly pharmacists across U.S. nursing homes. Res Soc Admin Pharm. 2026;22(7):785-789. https://doi.org/10.1016/j.sapharm.2026.03.006

Presentations

  • Haowen Hsu:
    • An ontology-informed strategy for medication interoperability in real-world data: from analytic feasibility to conceptual foundations. Presented at: 2026 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Conference; May 18, 2026; Philadelphia, PA.
    • Impact of medication clusters on post-discharge adverse drug events and healthcare utilization among older adults. Presented at: 2026 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Conference; May 19, 2026; Philadelphia, PA.
  • Sum Lam: See clearly through 3Ds—depression, dementia and delirium in older adults. Presented at: The 64th New York State Council of Health-System Pharmacists (NYSCHP) Annual Assembly; April 10, 2026; Saratoga Springs, NY.
  • Donna M. Lisi:
    • Strengthening community mental health infrastructure—the role of the psychiatric pharmacist in county and local government—the psychiatric pharmacist volunteer embedded in county and local government role in education, advocacy, and research. Presented at: American Association of Geriatric Psychiatry; April 28, 2026; Arlington, VA.
    • When vaccines become a choice: shared clinical decision making, informed consent, and “What Matters Most” as health literacy skills. Presented at: Institute for Healthcare Advancement (IHA) 25th Annual Virtual Health Literacy Conference; May 11-14, 2026; virtual.
    • The FDA drug approval process and gaps in health literacy that can impact patient care. Presented at: Institute for Healthcare Advancement (IHA) 25th Annual Virtual Health Literacy Conference; May 11-14, 2026; virtual.
  • Cavan O’Kane: Easing off, not cutting off: the evidence and role of pharmacists in opioid tapering. Presented at: 2026 New Jersey Pharmacists Association (NJPhA) Spring Symposium; April 18, 2026; Morristown, NJ.

New ACCP Fellows

  • Barbara J. Zarowitz

Other Notable Achievements

  • Judith Beizer: Elected as President-Elect of the American Geriatrics Society.
  • Sum Lam:
    • Installed as the President, Long Island Society of Health-System Pharmacists (LISHP), a chapter of the New York State Council of Health-System Pharmacists (NYSCHP).
    • Completed 22 years of service at NYU Langone Health – Long Island (formerly Winthrop University Hospital). Initiated geriatric pharmacy practice at St. Francis Hospital & Heart Center in Roslyn, New York—a hospital within the network of the Catholic Health Association of the United States.
  • Donna M. Lisi:
    • Obtained certification as a Certified Professional in Age-Friendly Healthcare (CPAFH) and as a Medical Professional Legal Consultant (MPLC).
    • Appointed to the Executive Committee of the New Jersey Local Boards of Health Association.
    • Reappointed as Chair of the Franklin Township Board of Health Advisory Council.
    • Started as Vice President of the Somerset County Office on Aging Advisory Council.
  • Barbara J. Zarowitz: Named Editor-in-Chief, Caring for the Ages.

Global Health PRN

Awards

  • Kylie Futrell: NACDS Foundation Faculty Scholars Program 2026-2027 Cohort, NACDS Foundation.

Grants

  • Kylie Futrell: NACDS Foundation Scholarship Program Innovation Track. Principal Investigator ($20,000).

Publications

  • Gibson CM, Escaño AK, Hobe KD, et al. Safety and effectiveness of somatostatin and analogues on chest tube output after coronary artery bypass grafting: a scoping review. J Cardiovasc Pharmacol. 2026;88(2):155-160. https://doi.org/10.1097/FJC.0000000000001810
  • DiVall MV, Dey S, Dang D, Gibson CM, et al. Flexible work arrangements in pharmacy academia: an overdue imperative. Am J Pharm Educ. 2026;90(9):102039. https://doi.org/10.1016/j.ajpe.2026.102039
  • O’Connell MB, Prescott GM, Allen M, Connor SE, Ford E, Formea CM, Gibson CM, et al. ACCP White Paper: From awareness to action: increasing health equity by addressing cultural and structural barriers in pharmacy practice, education, and research. J Am Coll Clin Pharm. 2026;9:e70206. https://doi.org/10.1002/jac5.70206
  • Kampanza M, Verbeeck R, Jonkman L, et al. Assessment of appropriate prescribing in maintenance haemodialysis and comparison of prescribing patterns between state- and privately-funded patients: a retrospective review. Hosp Pharm. 2026;61(4):356-365. https://doi.org/10.1177/00185787251403015
  • Schneider S, Connor S, Barik K, Jonkman LJ, et al. Development of a community-focused emergency response tool for medication-related preparedness. J Am Pharm Assoc (2003). 2026;66(1):102987. https://doi.org/10.1016/j.japh.2025.102987
  • Shagavah S, Ndungu M, Jonkman L, et al. The role of the pharmacist in healthcare nongovernmental organizations (NGOs): perspectives from key informant interviews. J Am Pharm Assoc (2003). 2026;66(1):102941. https://doi.org/10.1016/j.japh.2025.102941
  • Thikukutu M, Jonkman L, Singu B, et al. Factors influencing anticoagulation control of patients on warfarin therapy at Windhoek Central Hospital’s Warfarin Clinic. Hematology. 2026;31(1):2617678. https://doi.org/10.1080/16078454.2026.2617678
  • Thikukutu M, Jonkman L, Singu B, et al. Validation of the CoaguChek® XS-INR point-of-care analyzer to monitor the INR of patients at Windhoek Central Hospital, Namibia. Afr J Lab Med. 2026;15(1):a3023. https://doi.org/10.4102/ajlm.v15i1.3023
  • Ryan M, Isong C, Pérez DJ, et al. Addressing health equity through the development of the Health Equity Advisory Group and Health Equity Principles at USP. Pharmacopeial Forum. Published for comment May 1, 2026. https://doi.org/10.31003/USPNF_S203604_10101_01
  • Dueno M, Howington G, Ryan M. Utilization of adjunctive anti-seizure medications to facilitate chronic benzodiazepine discontinuation. Mental Health Clin. 2026;16:141-149. https://doi.org/10.9740/mhc.2026.06.141

Presentations

  • Caitlin Gibson:
    • Gibson CM, Blackwell J, Fontaine G. Anticoagulation in practice: stewardship, safety, and emerging indications. Presented at: Sentact Center for Clinical Excellence Safety Topics Webinar Series; May 2026; virtual.
    • Chronic care in cardiology. Presented at: American College of Clinical Pharmacy Annual Updates in Therapeutics® Webinar; May 2026; virtual.
    • Anticoagulant use among special populations. Presented at: Taiwan American College of Clinical Pharmacy Annual Meeting; March 2026; virtual.
    • Al Mazrouei N, Bhatt P, Bleidt B, Gibson CM, Lee M, Tangiisuran B, Ryan M (moderator). Breaking into pharmacy writing: a step-by-step guide for aspiring writers. Presented at: International Pharmaceutical Federation Webinar; March 2026; virtual.
  • Lauren Jonkman:
    • Brinkmann I, Jonkman L. Side effect burden and monitoring in patients on antipsychotics in the public health sector in Namibia. Presented at: Health Africa International Research Conference; March 2026; virtual.
    • Kampanza M, Brinkmann I, Simeon P, Nangombe V, Lates J, Jonkman L. ChatGPT said what? Evaluating the impact of an educational intervention on student perspectives on the use of generative AI for clinical queries. Presented at: Health Africa International Research Conference; March 2026; virtual.
    • Mater M, Simeon P, Jonkman L, et al. A Delphi approach to develop consensus on key entrustable professional activities for University of Namibia Bachelor of Pharmacy graduates. Presented at: Health Africa International Research Conference; March 2026; virtual.
  • Melody Ryan:
    • Educating in the era of artificial intelligence: a faculty conversation. Presented at: US-Thai Consortium for Improving Pharmacy Education in Thailand 2026 Meeting; June 2026; Iowa City, IA.
    • Professional identity formation in pharmacy in the era of artificial intelligence. Presented at: FIP Digital Events; July 2026; virtual.
    • Evaluating metacognitive development in an interprofessional education abroad experience. Presented at: 12th Biennial Monash Pharmacy Education Symposium; July 2026; Prato, Italy.
    • Transdisciplinary engagement in a global health case competition: a four-cohort retrospective analysis. Presented at: American Association of Colleges of Pharmacy Annual Meeting; July 2026; Grapevine, TX.

Other Notable Achievements

  • Alexandria Taylor: BC-ADM.

Health Equity PRN

Awards

  • Dinara Akolbekova: Distinguished Healthcare Worker, Ministry of Health of the Republic of Kazakhstan.
  • Jenna Cox: 2025-2026 Outstanding Mentor Award, University of South Carolina College of Pharmacy.
  • Jerika V. Nguyễn-Klatt: Presidential Citation Award, Society of Critical Care Medicine.

Promotions

  • Dinara Akolbekova: Head of Pharmacy, Burlin District Hospital, Aksai, Kazakhstan.
  • Jerika V. Nguyễn-Klatt: Clinical Pharmacy Specialist, Emergency Medicine, Trinity Health Grand Rapids, Grand Rapids, MI.

Grants

  • Jerika V. Nguyễn-Klatt: Intravenous Calcium Use During In-Hospital Cardiac Arrest. American College of Clinical Pharmacy Critical Care PRN Multicenter Research Grant. Principal Investigator.
  • Sharmon Osae: National Association of Chain Drug Stores Foundation Innovation Award, University of Georgia College of Pharmacy. Principal Investigator ($20,000).

Publications

  • Akolbekova D, Arystanov Z. Risk-based internal auditing in community pharmacies of Kazakhstan. Eurasian Sci Rev. 2026;767-776.
  • Akolbekova D, Arystanov Z. Improving the mechanisms of participation of pharmacy organizations in the implementation of outpatient pharmaceutical provision. Central Asian J Med Pract Res. 2025;98(suppl).
  • Akolbekova D, Arystanov Z. Structural imbalances in outpatient pharmaceutical provision and their impact on access to drug therapy in the Republic of Kazakhstan. Vestnik KRSU. 2026;26:228-232.
  • Akolbekova D, Arystanov Z. Regulatory barriers to opioid analgesic access in Kazakhstan. Discov Health Syst. 2026;5:64. https://doi.org/10.1007/s44250-026-00406-y
  • Akolbekova D, Arystanov Z. ATC-level drivers of imbalances in Kazakhstan’s outpatient medicines provision: a case study of distribution–utilization alignment in a centralized outpatient medicines system. Eurasian Sci Rev. 2026;3:7-22.
  • Akolbekova D, Arystanov Z. Integration of pharmacy organizations into the management system of outpatient pharmaceutical provision. In: Proceedings of the IX International Scientific and Practical Conference “Abu Ali Ibn Sino and Innovations in Modern Pharmacy.” Tashkent; 2026:455-456.
  • Akolbekova D, Arystanov Z. Effectiveness of organizational implementation of good pharmacy practice (GPP) principles in outpatient pharmaceutical care in Kazakhstan. Pharmacy of Kazakhstan 2026.
  • Akolbekova D, Arystanov Z. Dynamics of pharmaceutical provision for patients with diabetes mellitus in Kazakhstan: cost-volume analysis for 2019-2024 with updated data from the first half of 2025. Medicine. Sociology. Philosophy. Applied Research 2026.
  • Johnson ST, Cook K, Dallmeier J, et al. Hospital price transparency: a primer. Am J Health Syst Pharm. 2026;83(14):745-756. https://doi.org/10.1093/ajhp/zxag022
  • Forehand CC, Benken ST, Madorsky M, Mohamed A, Nguyễn-Klatt JV, et al. Pharmacotherapeutic controversies during temperature control after out-of-hospital cardiac arrest: a semi-structured literature review. Pharmacotherapy. 2026:46(1):e70095. https://doi.org/10.1002/phar.70095
  • O’Connell MB, Prescott GM, Allen M, Connor SE, Ford E, Formea CM, Gibson CM, Goodlet KJ, Jellinek-Cohen S, Mukherjee SM, Munir F, Nguyễn-Klatt JV, et al. From awareness to action: increasing health equity by addressing cultural and structural barriers in pharmacy practice, education, and research. J Am Coll Clin Pharm. 2026;9(4):e70206. https://doi.org/10.1002/jac5.70206
  • Osae SP, Chastain DB. Gaps between intended learning and practice in PGY1 pharmacy residency programs: alignment of training experiences with accreditation standards. J Pharm Pract. [In press]
  • Bradley KE, Chastain DB, Young HN, Osae SP. From pen to prompt: navigating LLM-generated content in postgraduate pharmacy training applications. Am J Pharm Educ. 2026;90(3):101947. https://doi.org/10.1016/j.ajpe.2026.101947
  • Harrigfeld S, Cunningham L, Layden B, Silva K, Smith Marsh D, et al. Screening rates and guideline-directed medical therapy use for chronic kidney disease in people with type 2 diabetes. Diabetes. 2026;75(suppl_1):2704-LB. https://doi.org/10.2337/db26-2704-LB

Presentations

  • Faria Munir, Sally Arif: Combating medical misinformation in the age of generative AI: health equity lens. Presented at: ACCP Drug Information PRN and Health Equity PRN CE Programming Committee Webinar; August 2026; virtual. Moderator: Maha Abdalla. Cross-PRN CE committee members: Maha Abdalla, Julie Sibbesen, Daphne Smith Marsh, Genevieve L. Engle, Sharon E. Connor.
  • Daphne Smith Marsh:
    • Bridging cultures and clinical care: navigating diabetes management in diverse dietary and fasting traditions. Presented at: Illinois Council of Health-System Pharmacists (ICHP) Spring Meeting; March 2026; Springfield, IL.
    • Coffee A, Schwartz A, Perez N, Smith Marsh D. Exploring cultural humility in student pharmacists. Poster presented at: AACP Pharmacy Education 2026; July 2026; Grapevine, TX.
    • Tran M, Smith Marsh D. Equity in diabetes care: the clinical pharmacist impact. Presented at: NPhA/SNPhA Annual Conference; August 2026; Rockville, MD.
  • Sharmon Osae: Diabetes dynamics: mastering the management of type 2 diabetes. Presented at: Flint River Nurse Practitioners Association Pharmacology Conference & Update; March 2026; Albany, GA.

Other Notable Achievements

  • Dinara Akolbekova:
    • Completed the MSPharm degree at Astana Medical University.
    • Invited Speaker, Global Mental Health Congress 2027, Singapore.
    • Developing ControlMed KZ, a national digital platform for controlled medicines management in Kazakhstan.
    • Author of methodological recommendations on implementation of Good Pharmacy Practice (GPP), approved by Astana Medical University.
  • Jerika V. Nguyễn-Klatt:
    • Chair-Elect, American College of Clinical Pharmacy Health Equity PRN.
    • Secretary, Society of Critical Care Michigan Chapter Board of Directors.

Health Outcomes PRN

Promotions

  • Sarah Billups: Full Professor, University of Colorado Skaggs School of Pharmacy.

Grants

  • Ligang Liu: ASHP Foundation Pharmacy Leadership Scholars Grant. Principal Investigator ($9990).

Publications

  • Billups SJ, Fraumeni BR, Bauguess HD, et al. Improving access to rheumatology care: evaluation of a rheumatology electronic consultation program. Arthritis Care Res. 2026;78(7):883-892. https://doi.org/10.1002/acr.70003
  • Haas K, Saseen J, Titus O, Lamberton N, Schilling LM, Hogan K, Marks A, Hogan KN, Marks A, Billups SJ. Blood pressure control among adherent versus nonadherent Medicare patients with hypertension. Am J Manag Care. 2026;32(7). [In press]
  • Lobo I, Koon K, Potthast K, Ozmina K, Billups SJ. A multi-intervention approach to blood pressure control: a description of how a large university based primary care clinic tackled hypertension. Popul Health Manage. 2026;26(1):18-26. https://doi.org/10.1177/19427891251393941
  • Salanio G, Fraumeni B, Linnebur SA, Billups S, et al. Qualitative assessment of provider perceptions of Medicare annual wellness visits (AWVs). Am J Health Promot. 2026 Jan 28. [Epub ahead of print]. https://doi.org/10.1177/08901171261421321
  • Liu L, Tao H, Zhao H, et al. Patterns of dietary supplement use for weight loss among U.S. adults with obesity: NHANES 2007-2020. J Obes. 2026;2026(1):e6761414. https://doi.org/10.1155/jobe/6761414
  • Leaman A, Liu L, Alashqar MT, et al. Efficacy and safety of combination pharmacotherapies with standard diuretic therapy in acute heart failure: a systematic review and meta-analysis. Cardiol Rev. 2026 Jun 18. [Epub ahead of print]. https://doi.org/10.1097/CRD.0000000000001337
  • Lin Y, Li H, Nahata MC, Zhang C, Ramey OL, Liu L. Treatment patterns and barriers to care among U.S. adults with co-occurring substance use disorder and mental illness. Am J Psychiatry. 2026 Jul 8. [Epub ahead of print]. https://doi.org/10.1176/appi.ajp.20251314
  • Tao H, Tan Y, Zhan R, Wang J, Peng L, Liu L. Trends in preclinical and clinical obesity among U.S. adolescents, 1999-2023. JAMA Pediatrics. [In press]
  • Wang L, Zhong S, Zhao J, Liu L, et al. Metabolic reprogramming-driven lactylation: emerging mechanisms linking DNA damage repair and chemoresistance in cancer. Cells. 2026;15(12):1073. https://doi.org/10.3390/cells15121073

Presentations

  • Ligang Liu:
    • National trends in weight-loss attempts, weight-loss strategies, and clinically meaningful weight loss among U.S. adults with diabetes and overweight or obesity, 1999-2023: a serial cross-sectional NHANES analysis. Presented at: ADA 2026 Scientific Sessions; June 5-8, 2026; New Orleans, LA.
    • Smoking prevalence and cessation indicators across glycemic states in U.S. adults: NHANES 2011-2023. Presented at: ADA 2026 Scientific Sessions; June 5-8, 2026; New Orleans, LA.
    • Major depressive episode and depression treatment among adolescents and young adults with vs without a cancer history in the United States, 2021-2024. Presented at: 2026 ACCP Virtual Poster Symposium; May 20, 2026; virtual.
    • Substance use patterns and correlates of polysubstance use among people living with HIV in the National Survey on Drug Use and Health, 2021-2024. Presented at: 2026 ACCP Virtual Poster Symposium; May 20, 2026; virtual.
    • Trends in weight-loss attempts, strategies, and clinically meaningful weight loss among US adults with hypertension and overweight or obesity, NHANES 1999-2023. Presented at: 2026 ACCP Virtual Poster Symposium; May 20, 2026; virtual.

Infectious Diseases PRN

Promotions

  • Spencer Durham: Clinical Professor of Pharmacy Practice, Auburn University Harrison College of Pharmacy, Auburn, AL.
  • Erika J. Ernst: Professor, University of Iowa College of Pharmacy, Iowa City, IA.
  • Alan E. Gross: Clinical Professor, University of Illinois Chicago Retzky College of Pharmacy, Chicago, IL.
  • Wesley D. Kufel: Clinical Professor, Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton, NY.
  • Hager Salaheldin: Solid Organ Transplant Clinical Pharmacotherapy Specialist, Bahrain Oncology Centre, King Hamad University Hospital, Bahrain.

Awards

  • Madison L. Adams:
    • Indian Health Service Navajo Area Junior Pharmacist of the Year, Indian Health Service Pharmacy Program.
    • Indian Health Service Pharmacy Preceptor of the Year, Indian Health Service Pharmacy Program/National Pharmacy Residency Program.
  • Christopher M. Bland: 25-Year Practitioner Award, Georgia Society of Health-System Pharmacists.
  • Crystal K. Hodge:
    • Outstanding Teaching Award, University of North Texas Health Science Center.
    • President’s Distinguished Faculty Award, University of North Texas Health Science Center.
  • Paula A. Politis: 2026 Stephanie Peshek Mentorship Award, Summa Health.
  • Hager Salaheldin: Honoring an exceptional AMS steward, King Hamad University Hospital (KHUH), Royal Medical Services, Kingdom of Bahrain.

Grants

  • Spencer Durham: Improving Antimicrobial Stewardship Across Alabama—Year 4. Alabama Department of Public Health. Principal Investigator ($135,830.77).

Publications

  • Berger JI, Anderson AD, Martinez OV, et al. Refractory and/or resistant herpes simplex virus mucocutaneous infections in adult transplantation and cellular therapy patients: a single-center experience. Cureus. 2026;18(6):e110131. https://doi.org/10.7759/cureus.110131
  • Camargo JF, Anderson AD, Spiegel J, et al. False-positive HIV-1 RNA detection following obecabtagene autoleucel. Bone Marrow Transplant. 2026 Jun 29. [Epub ahead of print]. https://doi.org/10.1038/s41409-026-02968-0
  • Camargo JF, Singireddy SS, Anderson AD. Possible increased risk of Epstein-Barr virus (EBV) infection and post-transplant lymphoproliferative disease (PTLD) in letermovir-exposed haematopoietic cell transplantation recipients. J Antimicrob Chemother. 2026;81(1):dkaf348. https://doi.org/10.1093/jac/dkaf348
  • Lopez CM, Suarez JF, Mendoza MA, Anderson AD, et al. Clinical characteristics and outcomes of invasive aspergillosis in patients with hematological malignancies and transplantation and cellular therapies in the contemporary era. Mycopathologia. 2026;191(2):29. https://doi.org/10.1007/s11046-025-01046-1
  • Osman-Kardash L, Alnajar A, Anderson AD, et al. Dasatinib exposure and risk of CMV reactivation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Am J Hematol. 2026 Jul 28. [Epub ahead of print]. https://doi.org/10.1002/ajh.70452
  • Raja M, Anderson A, Morris MI, et al. Viral culture conversion with use of remdesivir for respiratory syncytial virus lower respiratory tract infection. J Infect Dis. 2026 Jun 22. [Epub ahead of print]. https://doi.org/10.1093/infdis/jiag325
  • Mercado A, Badowski ME, Caliendo G, Bangalore N, Irwin AN, Noble JM, Chan DCM, Groth CM, Salvatus M, Parrish RH, Dumont ZJ, Sullivan JB, Nguyen T, Humaideh MA, Welch RW, et al. Key performance indicators for clinical pharmacy practice and administration in inpatient/acute care settings: an opinion of the Clinical Administration Practice and Research Network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2026;9(8):e70252. https://doi.org/10.1002/jac5.70252
  • Bennett A, Murray B, Sikora A, Reynolds E, Branan TN, Bland CM, et al. The weight debate: ideal versus total body weight for fluid resuscitation in septic shock. Am J Health Syst Pharm. 2026;83:e220-e226. https://doi.org/10.1093/ajhp/zxaf313
  • Bland CM, Branan TN, Ostendorf C, et al. IV push cefepime for Pseudomonas aeruginosa infections in critically ill patients: convenience over quality care? Am J Health Syst Pharm. 2026;83(7):e242-e243. https://doi.org/10.1093/ajhp/zxaf296
  • Alvarez-Arango S, Konvinse KC, Pujar M, Salciccioli IP, Bland CM, et al. Redefining diagnostic and management approaches to vancomycin adverse drug reactions. J Allergy Clin Immunol Pract. 2026;14(5):1034-1047. https://doi.org/10.1016/j.jaip.2026.02.008
  • Magagnoli J, Cummings TH, Bland CM, Sutton SS. Kidney injury, dialysis, and mortality with vancomycin plus piperacillin-tazobactam or cefepime. Int J Antimicrob Agents. 2026;67(11):107897. [Epub ahead of print]. https://doi.org/10.1016/j.ijantimicag.2026.107897
  • Smith SE, Bagodiya R, Luong P, Shinde S, Bland CM, Barry C, et al. Pharmacokinetic analysis of intravenous push cefepime in critically ill patients with sepsis. Pharmacotherapy. 2026;46:e70152. https://doi.org/10.1002/phar.70152
  • Smith SE, Bland CM, Branan TN. Response to comment on “Pharmacokinetic analysis of intravenous push cefepime in critically ill patients with sepsis.” Pharmacotherapy. 2026;46:e70187. https://doi.org/10.1002/phar.70187
  • Covington EW, Clark L, Pritchett C, et al. Integrating clinical pharmacists into emergency department culture follow-up: a head-to-head comparison of workflow models. JACP Open. 2026;2(2):22-32. https://doi.org/10.67122/001c.162647
  • Cyr E, Argotsinger J, Beck ET, Chamberland RR, Clark AE, Daniels AR, Liesman R, Fisher M, Gialanella P, Hand J, Harrington AT, Humphries RM, Huse H, Hamilton-Seth R, Hankins JD, Kufel WD, Riddell SW, Mehta M, Demkowicz R, Mochon AB, Salimnia H, Khan A, Pierce VM, Potula R, Tekle T, Simner PJ, Tibbetts R, Vu C, et al. Antimicrobial activity of sulbactam-durlobactam against Acinetobacter baumannii-calcoaceticus complex strains causing non-respiratory and non-bloodstream infections from the United States (2023-2025). Microbiol Spectr. 2026;14(5):e0328925. https://doi.org/10.1128/spectrum.03289-25
  • Durham SH, Chahine EB. Zoliflodacin: a novel single-dose oral antibiotic for uncomplicated urogenital gonorrhea. Am J Health Syst Pharm. 2026 Jul 3. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxag204
  • Durham SH, McAllister AK, Chahine EB. Gepotidacin for the treatment of uncomplicated urogenital gonorrhea. Ann Pharmacother. 2026 Apr 10. [Epub ahead of print]. https://doi.org/10.1177/10600280261435593
  • El Khatib O, Zekery-Saad S, Abidi E, Abdelaziz A, Abu Tabar O, Ahmed M, Farooq A, El Nekidy WS. Influence of kidney function estimation methods on carboplatin dosing and clinical outcomes. Ann Pharmacother. 2026 Apr 3. [Epub ahead of print]. https://doi.org/10.1177/10600280261430829
  • Aljumaa SA, Al Musawa M, El Lababidi R, Abidi E, Ghazi I, El Nekidy WS. Comment on “Evaluation of high dose post-dialytic versus daily beta-lactam dosing in hemodialysis patients using Monte Carlo simulation.” Int J Clin Pharm. 2026;48(3):1185-1186. https://doi.org/10.1007/s11096-026-02127-x
  • Malaeb D, Younes S, Barakat M, Jaber A, El-Labbad EM, Hassan BAR, Salim R, Al-Jewari WM, Mosleh R, Al Ayoubi F, Jawad H, Hallit S, El Said NO, El Nekidy WS. Insights into perceptions, motivations, and barriers toward board certification among pharmacists in Middle East countries: a cross-sectional study. J Am Coll Clin Pharm. 2026;9(8):e70256. https://doi.org/10.1002/jac5.70256
  • Younes S, Barakat M, El-Labbad EM, Omar El Said N, Jaber A, Sawan ES, El Nekidy WS, et al. Influence of board-certified preceptors on pharmacy students’ intention to pursue specialty certification. Am J Pharm Educ. 2026;90(9):102042. https://doi.org/10.1016/j.ajpe.2026.102042
  • Shaw M, Derrick C, Crocker RJ, Harris N, Pizzuti M, Justo JA, Frens JJ, Kufel WD, Corvino DL, Krekel T, Kabbani S, Brock J, Derringer J, Kinn P, Díaz-Pollán B, Antolí AC, Bookstaver PB. Evaluating dalbavancin suppression therapy in patients at high risk for recurrent infections. Ann Pharmacother. 2026 May 26. [Epub ahead of print]. https://doi.org/10.1177/10600280261445133
  • Kunz Coyne AJ, Bouchard J, Durham SH, Kang AY, Johannemann KM, Moore WJ, Nguyen K, Sanders J, Sheveland C, Stimes G, Trinh T, Covington EW. Oral β-lactams for complicated urinary tract infections: a systematic review and point-counterpoint comparison with trimethoprim/sulfamethoxazole and fluoroquinolones. Pharmacotherapy. 2026;46(3):e70118. https://doi.org/10.1002/phar.70118
  • Kunz Coyne AJ, Judd C, Lucas K, Al Musawa M, Van Helden S, Holger D, Althubyani A, Yost C, VanDorf S, Mynatt R, Kufel WD, Hayes J, Deri CR, Wrenn RH, Slaton CN, Morrisette T, Davis M, Cabanilla MG, Shald E, White BP, Sassine J, Truong J, Rosenberg J, Andrade J, Cerenzio J, Medvedeva N, Ha D, Eubank TA, Garey KW, Biagi M, Todd M, Kang-Birken SL, Rux C, Molina KC, Jankowski CA, Claeys KC, Venugopalan V, Veve MP, Orzol C, Eshaya M, Caniff KE, Bleick C, Rybak MJ. Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centers. Antimicrob Agents Chemother. 2026;70(6):e00268-26. https://doi.org/10.1128/aac.00268-26
  • Orlikowski C, Torney N, Hunt A. Operationalizing single-dose long-acting lipoglycopeptides for treatment of ABSSSI in a U.S. community hospital emergency department. Clin Drug Investig. 2026 Jul 29. [Epub ahead of print]. https://doi.org/10.1007/s40261-026-01585-5
  • Polisetty RS, Durham SH, Rohani R, Cluck DB, Sherman E, Hodge CK, Huesgen E, Sahloff E, Nhean S, Badowski M, Brizzi M, Shaeer KM. Need for more HIV-trained pharmacists due to unmet needs and expanding opportunities: an opinion of the HIV Practice and Research Network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2026;9(1):e70160. https://doi.org/10.1002/jac5.70160
  • Politis PA, File TM. Use of procalcitonin as a tool to enhance antimicrobial stewardship. Clin Infect Dis. 2026 Apr 15. [Epub ahead of print]. https://doi.org/10.1093/cid/ciag166
  • Salah H, Shaaban AH, Abdelrahman MA, et al. Efficacy and safety of duloxetine with gabapentin or amitriptyline versus duloxetine monotherapy in chemotherapy-induced peripheral neuropathy: randomized controlled trial. Pharmaceuticals. 2026;19(4):553. https://doi.org/10.3390/ph19040553
  • Monogue ML, Sanders JM, Mercuro NJ, Hodge CK, Golnabi E, et al. Antimicrobial pharmacokinetic and pharmacodynamic considerations in special populations: a call to action. Open Forum Infect Dis. 2026;13(3):ofag093. https://doi.org/10.1093/ofid/ofag093
  • Swanson A, Schwarz JS, Bektas AN, et al. Use of prucalopride in severe ileus in a critically ill patient with acute alcoholic hepatitis and hepatic encephalopathy. ACG Case Rep J. 2026;13(7):e02248. https://doi.org/10.14309/crj.0000000000002248
  • Morrisette T, Stimes GT, Alvira-Arill GR, Lockowitz CR, Yuenger V, Facer EE, Huang A, Holger DJ, Althubyani AA, El Ghali A, Kesner J, Kufel WD, Santevecchi BA, Venugopalan V, Olney KB, Newland JG, Shelley J, Walsh L, Wilson WS, et al. Multicenter evaluation of ceftazidime/avibactam in pediatric patients across the United States: real-world insights into the management of drug-resistant gram-negative infections. Open Forum Infect Dis. 2026;13(4):ofag177. https://doi.org/10.1093/ofid/ofag177
  • Burvenich R, Broder JC, Wang Y, Verbakel JY, Ryan J, Orchard SG, Wolfe R, Ernst EJ, et al. Antibiotic use in older Australians with and without dementia in primary care. Age Ageing. 2026;55(2):afag014. https://doi.org/10.1093/ageing/afag014

Presentations

  • Madison L. Adams: A day in the life of an antimicrobial stewardship (AMS) pharmacist: meeting CDC core elements through workflow operations. Presented at: Indian Health Service Southwest Regional Pharmacy Meeting; May 2026; Phoenix, AZ.
  • Elizabeth W. Covington:
    • Applications of artificial intelligence in pharmacy practice and education. Invited panelist at: 2026 US-Thai/US-ASEAN Pharmacy Consortia Meeting; June 2026; Iowa City, IA.
    • Wrangling the robots: real-world fixes for AI implementation barriers. Presented at: AACP Annual Meeting; July 2026; Grapevine, TX.
    • Build-a-bot workshop: designing intentional AI-powered learning activities. Presented at: AACP Technology in Pharmacy Education and Practice Tech Talk; April 2026; virtual.
    • Using AI without losing your clinical reasoning: a practical guide for medical students. Presented at: VCOM-Auburn; July 2026; Auburn, AL.
    • From quick prompts to custom bots: practical AI for pharmacy. Presented at: Auburn University Harrison College of Pharmacy Live@Lunch Continuing Education Webinar; June 2026; virtual.
    • Precepting in the age of AI: practical and ethical use of AI in pharmacy residency training. Presented at: University of Oklahoma Medical Center Continuing Education Webinar; April 2026; virtual.
    • Where do preceptors draw the line? Student use of generative AI in experiential education. Presented at: AACP Annual Meeting; July 2026; Grapevine, TX.
    • The wild west of generative AI: characterizing preceptor adoption and uses in experiential education. Presented at: AACP Annual Meeting; July 2026; Grapevine, TX.
    • Pharmacist-led transitions of care intervention to address infectious disease tests pending at discharge (TPAD). Presented at: MAD-ID/SIDP Annual Meeting; May 2026; Orlando, FL.
  • Elizabeth W. Covington, Wesley D. Kufel: Leveraging artificial intelligence to improve ID pharmacy practice and education. Presented at: Society of Infectious Diseases Pharmacists Webinar; February 12, 2026; virtual.
  • Cynthia T. Nguyen: Looking for the needle in a haystack: identifying stewardship opportunities in chronic suppressive antimicrobial therapy—pro: finding the needle in the haystack. Presented at: SHEA Spring 2026 Conference; April 2026; Chicago, IL.
  • Jacob S. Schwarz:
    • Distilled wisdom: pharmacy clinical pearls. Presented at: Arizona Pharmacy Association Annual Meeting; June 2026; Scottsdale, AZ.
    • Distilling evidence: journal club and biostatistical evaluation. Presented at: Arizona Pharmacy Association Annual Meeting; June 2026; Scottsdale, AZ.

New ACCP Fellows

  • Erika J. Ernst

Other Notable Achievements

  • Hunter Curry: BCIDP.
  • Erika J. Ernst: BCIDP.
  • Courtney Jackson: BCIDP.
  • Wesley D. Kufel: Appointed to the editorial board of Antimicrobial Stewardship & Healthcare Epidemiology.
  • Cynthia T. Nguyen: Appointed Vice Chair of the antimicrobial stewardship track for the SHEA Spring Conference.
  • Paula A. Politis: Completed the 2026 IDSA Community of Leaders Program.
  • Jacob S. Schwarz: Completed a term as President of the Arizona Pharmacy Association after 10 years of service on its Board of Directors.

Nephrology PRN

Promotions

  • Linda Awdishu: Chair, Department of Pharmacy Practice and Sciences, University of California, San Diego Skaggs School of Pharmacy & Pharmaceutical Sciences.

Awards

  • Linda Awdishu: Elsevier Raise the Line Faculty Award Nominee 2026.

Grants

  • Melanie Weltman:
    • Development of a Pharmacist-Led Population Health Management Program to Optimize Guideline-Recommended Medication Therapy in Chronic Kidney Disease. Mentored Patient-Oriented Research Career Development Award, National Institute of Diabetes and Digestive and Kidney Diseases. Principal Investigator ($950,047).
    • Enhancing PCP-Nephrologist Co-Management for CKD: Leveraging Population Health Management and Learning Health System for Scalable Solutions, National Institute of Diabetes and Digestive and Kidney Diseases. Co-Investigator ($1.76 million).

Publications

  • Awdishu L, Karger AB, Shlipak MG, Estrella MM. Use of cystatin C in tandem with creatinine to improve GFR estimation and clinical decision making. J Am Soc Nephrol. 2026 Jul 9. [Epub ahead of print]. https://doi.org/10.1681/ASN.0000001201
  • Gist KM, Selewski DT, Kashani KB, Akcan-Arikan A, Annich G, Antonini MV, Askenazi D, Awdishu L, et al. Extracorporeal membrane oxygenation, acute kidney injury, fluid balance, and continuous renal replacement therapy: Acute Disease Quality Initiative (ADQI) and Extracorporeal Life Support Organization (ELSO) joint consensus conference. Intensive Care Med. 2026;52(6):1175-1195. https://doi.org/10.1007/s00134-026-08440-3
  • Hean AC, Mathew R, Chu F, Awdishu L. Vancomycin clearance compared to creatinine clearance by timed urine collection in the intensive care unit. Int J Antimicrob Agents. 2026;67(2):107704. https://doi.org/10.1016/j.ijantimicag.2025.107704
  • Lam CSP, Bozkurt B, Cherney DZI, et al; (Awdishu L, as a member of the Conference Participants). Kidney disease and heart failure: recent advances and current challenges: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2026;109(6):1095-1113. https://doi.org/10.1016/j.kint.2025.10.011
  • Zhou C, Gruenberg K, Valle-Oseguera CS, Awdishu L, et al. Collaborative development of a shared objective structured clinical examination to assess the pharmacist patient care process across two PharmD programs. Curr Pharm Teach Learn. 2026;18(4):102526. https://doi.org/10.1016/j.cptl.2025.102526
  • El Khatib O, Zekery-Saad S, Abidi E, Abdelaziz A, Abu Tabar O, Ahmed M, Farooq A, El Nekidy WS. Influence of kidney function estimation methods on carboplatin dosing and clinical outcomes. Ann Pharmacother. 2026 Apr 3. [Epub ahead of print]. https://doi.org/10.1177/10600280261430829
  • Malaeb D, Younes S, Barakat M, Jaber A, El-Labbad EM, Hassan BAR, Salim R, Al-Jewari WM, Mosleh R, Al Ayoubi F, Jawad H, Hallit S, El Said NO, El Nekidy WS. Insights into perceptions, motivations, and barriers toward board certification among pharmacists in Middle East countries: a cross-sectional study. J Am Coll Clin Pharm. 2026;9(8):e70256. https://doi.org/10.1002/jac5.70256
  • Younes S, Barakat M, El-Labbad EM, Omar El Said N, Jaber A, Sawan ES, El Nekidy WS, et al. Influence of board-certified preceptors on pharmacy students’ intention to pursue specialty certification. Am J Pharm Educ. 2026;90(9):102042. https://doi.org/10.1016/j.ajpe.2026.102042
  • St. Peter WL, Neumiller JJ, Alicic R, et al. A scoping review of pharmacist-based interprofessional interventions for management of cardiovascular-kidney-metabolic conditions. J Am Coll Clin Pharm. 2026;9(4):e70198. https://doi.org/10.1002/jac5.70198
  • Ndumele CE, Rodriguez F, Dixon DL, Khan SS, Mukherjee D, Bajaj M, Bangalore S, Bozkurt B, Breathett K, Clarke SL, de Boer IH, Ellison DH, Evangelista LS, Heffron SP, Kazi DS, Kulshreshtha A, Lingvay I, Wang CCL, Mercado CA, Morton JM, Neeland IJ, Pagidipati N, Powell-Wiley TM, Rangaswami J, Rao G, Reza N, Saeed A, St. Peter WL, et al. 2026 AHA/ACC/ADA/ASN guideline for the prevention, detection, evaluation, and management of cardiovascular-kidney-metabolic syndrome: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026;154(4):e50-e158. https://doi.org/10.1161/CIR.0000000000001453
  • Umaru O, Pestka DL, Sorge LA, Cheng Chi-Han, Dryden K, Rangaswami J, Tuttle R, Brummel A, *Neumiller JJ, *St. Peter WL. Gaps, barriers, and facilitators to implementing comprehensive medication management in cardiovascular-kidney-metabolic care: a qualitative study. J Am Coll Clin Pharm. 2026;e70253. https://doi.org/10.1002/jac5.70253 (*co-senior authors)
  • Weltman MR, Lavenburg LU, Zupa MF, et al. Barriers to use of cardio-kidney protective medications in chronic kidney disease: results of a nephrology provider survey. Kidney Med. 2026 Jul 16. [Epub ahead of print]. https://doi.org/10.1016/j.xkme.2026.101474

Presentations

  • Linda Awdishu:
    • Drug dosing in AKI and RRT. Presented at: AKI & CRRT 2026 (31st International Conference on Advances in Critical Care Nephrology); March 29–April 1, 2026; San Diego, CA.
    • Breaking the Cockcroft-Gault habit: clinical pharmacy’s role in the shift to eGFR. Presented at: 9th Annual UC Pharmacy Collaborative Conference; May 14, 2026; Davis, CA.
    • Implementing 2024 AHA hypertension guidelines: novel agents for resistant and complex hypertension. Presented at: Updates in Therapeutics® Conference; June 6, 2026; Del Mar, CA.
  • Wendy St. Peter:
    • Reimagining renal assessment: pros and cons. Presented at: JACCP Podcast; May 12 2026; virtual.
    • Practice transformation: making eGFR the standard for CKD dosing. Presented at: ASHP Podcast; June 9, 2026; virtual.

Other Notable Achievements

  • Linda Awdishu:
    • Member, National Kidney Foundation Scientific Advisory Board.
    • Member, San Diego AKI & CRRT Nursing and Allied Professionals Award “Advancing Excellence in AKI & CRRT Care at the Bedside” award selection committee.
    • Co-Chair, National Kidney Foundation Workgroup on KDOQI Commentary on 2025 American Heart Association/American College of Cardiology Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.

Pain and Palliative Care PRN

Awards

  • Jacqueline Cleary: NYSCHP Residency Research & Practice Forum 2026 Preceptor Excellence Award.
  • Emily M. McGovern: Preceptor of the Year, 2025-2026, Stratton VA Medical Center, PGY2 Pain Management and Palliative Care Pharmacy Residency Program, Albany, NY.
  • Mary Lynn McPherson: 2026 American Academy of Hospice and Palliative Medicine (AAHPM) Award for Excellence in Education and Training.

Publications

  • Taylor A, Phillippe H, Fox B, Marlowe K, et al. Prescription drug monitoring program perceptions before and after an interprofessional workshop: a theory-informed longitudinal survey study. Front Digit Health. 2026;8:1746715. https://doi.org/10.3389/fdgth.2026.1746715
  • Taylor A, Hohmann L, Fox B, Marlowe K, et al. A K-12 school–based substance misuse prevention program in partnership with a college of pharmacy: pilot program development and implementation. JAPhA Pract Innov. 2026;3(2):100105. https://doi.org/10.1016/j.japhpi.2026.100105
  • Khan S, Andrews R, Chamberlin KW, Mitchell M, et al. Multidisciplinary eConsults to optimize safe opioid prescribing: a pilot program. J Pain Palliat Care Pharmacother. 2026 May 7. [Epub ahead of print]. https://doi.org/10.1080/15360288.2026.2663400
  • Riccio K, Whittaker A. Impact of interprofessional education on health professional student knowledge and stigmatizing beliefs related to substance use disorders: a pre-post analysis. J Am Coll Clin Pharm. 2026;9(2):e70151. https://doi.org/10.1002/jac5.70151
  • Riccio KKC. Confronting the undertreatment of opioid use disorder in pregnancy: from hesitation to action. Am J Health Syst Pharm. 2026;83(11):e432-e436. https://doi.org/10.1093/ajhp/zxaf340
  • Elder R, He P, Fuller A, Nadella S, Theken KN, Panchal N. Impact of preoperative anemia on surgical success in medication-related osteonecrosis of the jaw. J Oral Maxillofac Surg. 2026 Jul 22. [Epub ahead of print]. https://doi.org/10.1016/j.joms.2026.07.021
  • Miller CJ, DeLorey I, Bilker WB, Argoff CE, Bell RL, Gewandter JS, Gilron I, Haythornthwaite JA, McWilliams T, Theken KN, et al. Duration of clinically meaningful improvement in pain as a patient-centered endpoint in acute pain trials. Pain. 2026167(9):2171-2179. https://doi.org/10.1097/j.pain.0000000000004037
  • van den Dries SR, Panchal N, Wang S, Habib RA, Ford BP, Secreto SA, Hersh EV, Theken KN. Oral and maxillofacial surgeon accuracy in anticipating supplemental opioid use following third molar extraction. medRxiv. [preprint]. 2026 Jul 6. https://doi.org/10.64898/2026.07.02.26357136

New ACCP Fellows

  • Jacqueline Cleary

Presentations

  • Maria Felton Lowry: Ketamine use for refractory symptoms in hospice. Presented at: 2026 Society of Pain and Palliative Care Pharmacists (SPPCP) Virtual Conference; May 19, 2026; virtual.
  • Lisa Luciani:
    • Smarter pain control: leveraging multimodal strategies for better patient outcomes. Presented at: 2026 Florida Society of Health-System Pharmacists (FSHP) 60th Annual Meeting; August 7, 2026; Orlando, FL.
    • Medication management: what guides our choices? Presented at: American Academy of Pain Medicine (AAPM) PainConnect 2026; March 5, 2026; Salt Lake City, UT.
    • Restless relief: double-edged sword of pain and sleep. Presented at: American Academy of Pain Medicine (AAPM) PainConnect 2026; March 5, 2026; Salt Lake City, UT.
    • Analgesics of the future: from bench to bedside. Presented at: American Academy of Pain Medicine (AAPM) PainConnect 2026; March 7, 2026; Salt Lake City, UT.
  • Neil Shah: Buprenorphine induction discussions. Presented at: Pennsylvania Society of Health-System Pharmacists (PSHP) Annual Meeting; March 31, 2026; Lancaster, PA.

Other Notable Achievements

  • Megan Carr: Fellow, American Geriatrics Society.
  • Jacqueline Cleary: The American Medical Association (“AMA”) subject matter expert to assist in the development of a toolkit to better support community health center (CHC) clinicians in their implementation of the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain.
  • Lucas Hill: Executive Director, Implementation and Research Center for Healthy Communities (IRC).
  • Lisa Luciani:
    • Accepted into the 2026-2027 ACCP Professional Leadership Development (APLD) Program.
    • Featured in American Academy of Pain Medicine (AAPM) Member Focus.
    • Pharmacist Representative for American Academy of Pain Medicine (AAPM) 2027 and 2026 Annual PainConnect Meeting Program Committee.
    • Academic appointment as Assistant Professor of Pharmacology, University of Central Florida College of Medicine, Orlando, FL.
  • Emily McGovern, Thomas Gregory, Lisa Luciani: American College of Clinical Pharmacy (ACCP)/American Society of Health-System Pharmacists (ASHP) Pain Management Pharmacy Preparatory Review Course Planning Committee Member.

Pediatrics PRN

Awards

  • Kari Allan, Luke Orth: Best Practice Award, Pediatric Pharmacy Association, awarded jointly.

Grants

  • Kari Allan, Luke Orth: Expansion of Clinical Pharmacy Services for Children and Youth with Special Healthcare Needs in a Predominately Medicaid-Serviced Population (renewed). Funding Agency: CO Department of Health Care Policy and Finance. Co-Primary Investigators ($174,275). July 2026 – June 2027.

Publications

  • Branton R, Farrington E. Evaluation of opioid administrations after laparoscopic appendectomy in pediatrics with perforated versus non-perforated appendicitis: a retrospective cohort study. J Pediatr Pharmacol Ther. 2026;31(4):523-528. https://doi.org/10.5863/JPPT-25-00076
  • Brunstetter C, Fenn NE. Safety and efficacy of oral azithromycin for gastrointestinal dysmotility in pediatric patients. J Pediatr Pharmacol Ther. 2026;31(3):407-412. https://doi.org/10.5863/JPPT-25-00064
  • Johnson PN. The work that changed me: my story of growing up and overcoming growing pains through pediatric pharmacy. J Pediatr Pharmacol Ther. 2026;31(3):306-321. https://doi.org/10.5863/JPPT-26-00108
  • Johnson PN, Brahm N, Galbraith W, et al. Implementation of curricular track programs at a college of pharmacy over a 15-year period. Curr Pharm Teach Learn. 2026;18(7):102642. https://doi.org/10.1016/j.cptl.2026.102642
  • Kiskaddon AL, Johnson PN, Dallas L, Stang C, Beckman E, Gattis S, et al. Pharmacist antithrombotic interventions in critically ill children: a multicenter prospective study. Am J Health Syst Pharm. 2026 May 18. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxag117
  • Luke M, Johnson PN, Neely SB, et al. Frequency of massive diphenhydramine ingestions in children 6-18 years of age. Clin Toxicol (Phila). 2026 Jun 18. [Epub ahead of print]. https://doi.org/10.1080/15563650.2026.2680177
  • Malehorn EN, Blumenthal M, Miller JL, Stephens KS, Lewis TV, Lim SY, Johnson PN. Pharmacokinetic analysis of conventional tobramycin dosing for infants in the cardiac intensive care unit. Pediatr Res. 2026 Jun 11. [Epub ahead of print]. https://doi.org/10.1038/s41390-026-05158-2
  • Parman A, Shrestha M, Miller JL, Oldham MM, Neely S, Johnson PN. Bacterial resistance associated with inhaled tobramycin for prevention of ventilator-associated tracheitis in mechanically ventilated neonates and children without cystic fibrosis: an observational pilot study. J Pediatr Pharmacol Ther. 2026;31(2):274-278. https://doi.org/10.5863/JPPT-25-00068
  • Jain R, Taylor JL, Kazmerski TM, Lonabaugh K, et al. Reproductive health guidance for the cystic fibrosis community: a Cystic Fibrosis Foundation position paper. Lancet Respir Med. 2026;14(8):730-746. https://doi.org/10.1016/S2213-2600(26)00120-7
  • Kemp H, Manasco KB. Impact of a formulary change and implementation of a legacy medication alternative in the electronic medical record on antibiotic prescribing in children. J Pediatr Pharmacol Ther. 2026;31(4):509-515. https://doi.org/10.5863/JPPT-25-00069
  • Matson KL, Johnson PN, Tran V, et al; Advocacy Committee on behalf of Pediatric Pharmacy Advocacy Group. Opioid use in children. J Pediatr Pharmacol Ther. 2019;24(1):72-75. https://doi.org/10.5863/1551-6776-24.1.72
  • McPherson AZ, Miller M, Rytlewski K, et al. Magnusiomyces clavatus fungemia treated with combination antifungals including isavuconazole in an immunocompromised pediatric patient: a case report. Ther Adv Infect Dis. 2026;13:20499361261457479. https://doi.org/10.1177/20499361261457479
  • Cluck DB, White BP, Hilzendager SA, Ryder JH, Tu PJ, McPherson AZ, et al. Clinical controversies in the management of candidemia in adults and children. Am J Health Syst Pharm. 2026 Jul 11. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxag212
  • Byerley EM, McCoy KS, Eisner M, Johnson T, Novak KJ, et al. De-escalation of medications after initiation of elexacaftor-tezacaftor-ivacaftor in children 6 to 11 years of age with cystic fibrosis. J Pediatr Pharmacol Ther. 2026;31(4):501-508. https://doi.org/10.5863/JPPT-25-00051
  • Fava J, Stephan E, Tansmore J, Sheikh S, Eisner M, Novak KJ. Impact of elexacaftor/tezacaftor/ivacaftor on systemic antibiotic utilization in pediatric patients with cystic fibrosis. Pediatr Pulmonol. 2026;61(8):e71749. https://doi.org/10.1002/ppul.71749
  • Orth LE, Reedy J, Thompson T, et al. Caregiver perspectives on polypharmacy management in children with medical complexity. Pediatrics. 2026;158(2):e2025075527. https://doi.org/10.1542/peds.2025-075527
  • Elsbernd A, Grills N, Antoon JW, Kyler KE, Orth LE, et al. Current practices of index hospitalization anticoagulant use in pediatric patients with acute myeloid leukemia. Blood Vessel Thromb Hemost. 2026;3(3):100178. https://doi.org/10.1016/j.bvth.2026.100178
  • Jenkins AM, Hendry E, Power-Hays A, Valentino M, Hall M, Kyler KE, Antoon JW, Tang Girdwood S, Goldman JL, Morel AN, Savage TJ, Orth LE, et al. Increasing ketamine administration in children’s hospitals for youth with sickle cell disease. Blood Adv. 2026;10(4):1106-1113. https://doi.org/10.1182/bloodadvances.2025016826
  • Dollimer O, Raschka M, Dassenko D. Approach to the preoperative pharmacological management of catecholamine-secreting tumors in children: a case series and review. J Pediatr Pharmacol Ther. 2026;31(3):419-426. https://doi.org/10.5863/JPPT-25-00032
  • Sabet S, Hollman N, Hendrix-Dicken A, Raschka M, et al. HIV-specific vs universal immunization coverage in US children with HIV: a multi-site study. J Pediatric Infect Dis Soc. 2026;15(5):piag026. https://doi.org/10.1093/jpids/piag026
  • Spyhalsky AM, Welter KJ, DeVine MN, et al. Intermittent subcutaneous unfractionated heparin for venous thromboembolism prophylaxis in pediatric intensive care unit patients. Pediatr Blood Cancer. 2026 Jul 23. https://doi.org/10.1002/1545-5017.70524
  • Fly JH, Stultz JS, Eiland LS. Advancements in respiratory syncytial virus (RSV) prevention and treatment in pediatrics. J Pediatr Pharmacol Ther. 2026;31(3):322-338. https://doi.org/10.5863/JPPT-25-00075

Presentations

  • Allan K, Orth LE. Improved adherence to antipsychotic monitoring guidelines in children with special health care needs. Presented at: PPA Annual Meeting; April 2026; Arlington, VA.
  • Orth LE. Beyond gut feelings: reviewing the role of psychotropic meds in functional GI management. Presented at: Developmental Pediatrics Psychopharmacology Conference; January 2026; Aurora, CO.
  • Orth LE, Lee B. Evidence-based communication on vaccines and autism: empowering clinicians and caregivers. Presented at: ACCP (standalone) education series; February 2026; virtual.

New ACCP Fellows

  • Elizabeth J. Beckman
  • Lea S. Eiland
  • Peter N. Johnson
  • Jennifer Morris Daniel

Other Notable Achievements

  • Norm Fenn: Faculty APPE Preceptor of the Year, Manchester University.
  • Mike Raschka:
    • APPE Preceptor of the Year, University of Minnesota School of Pharmacy.
    • Appointment to the Measles Collaborative, launched in July 2026 by the National Foundation for Infectious Diseases.

Perioperative Care PRN

Promotions

  • Shinelle Green: Medication Safety Coordinator, Johns Hopkins Bayview Medical Center, Baltimore, MD.

Publications

  • Linn DD, Renew JR. Postoperative benefits of sugammadex: a narrative review. Am J Health Syst Pharm. 2026;83(5):e183-e191. https://doi.org/10.1093/ajhp/zxaf213
  • Linn DD, Renew JR, Brull SJ. Beyond the hype: understanding the limitations of sugammadex. Am J Health Syst Pharm. 2026;83(16):835-844. https://doi.org/10.1093/ajhp/zxag094
  • Renew JR, Linn DD, Logvinov II, et al. The impact of the “2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade” on quantitative neuromuscular monitoring two years later. Anesth Analg. 2026 Jun 25. [Epub ahead of print]. https://doi.org/10.1213/ANE.0000000000008190
  • Cisar C, Wolfe RC. Propofol frenzy: detection and management of propofol-induced neuroexcitation in the perioperative setting. J Perianesth Nurs. 2026;41(4):1084-1087. https://doi.org/10.1016/j.jopan.2026.04.014
  • Roberts I, Cisar C, Wolfe RC. Postoperative shivering: a review of mechanisms and management strategies. J Perianesth Nurs. 2026;41(2):538-541. https://doi.org/10.1016/j.jopan.2026.01.005

Presentations

  • Rachel Wolfe:
    • PONV: guideline updates and interval literature developments. Presented at: ACCP Perioperative Care PRN Webinar; May 2026; virtual.
    • SAFE-NMB: standardized, systematic, and sustainable implementation of quantitative neuromuscular blockade monitoring to reduce residual paralysis. Poster presented at: Clay Dunnagan PSQ Symposium; March 6, 2026; St. Louis, MO.
    • Continuous interscalene catheters vs. single-injection nerve block plus bupivacaine-meloxicam ER solution for postoperative pain following total shoulder arthroplasty. Poster presented at: American Society of Regional Anesthesia 51st Annual Meeting; April 18, 2026; Phoenix, AZ.

Other Notable Achievements

  • Rachel Wolfe: Voluntary faculty appointment – Voluntary Clinical Assistant Professor, Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO.

Pharmacokinetics/Pharmacodynamics/Pharmacogenomics PRN

Promotions

  • Roseann S. Donnelly: Professor, Massachusetts College of Pharmacy and Health Sciences.
  • Natasha J. Petry: Full Professor, North Dakota State University.

Publications

  • Baye JF, Petry NJ, Hines L, Weaver M, Reinke M, Brady H, Massmann A, Schultz A. Genotype influences antidepressant discontinuation in a pre-emptive pharmacogenetic testing population. Pharmacogenomics J. 2026;26(3):22. https://doi.org/10.1038/s41397-026-00416-2
  • Blake KV, Hines LJ, Liu M, Myers RA, Baye JF, Cavanaugh KL, Duong BQ, Hulvershorn LA, Mathews CA, Murrough JW, Orlando LA, Petry NJ, Tillman EM, Sadeghpour A, Voora D, Block SL, Cicali EJ, Clermont S, Elwood EN, Harris EC, Nguyen KA, Ramos MA, Rosenman MB, Shroff N, Shuman S, Wyatt C, Horowitz CR, Volpi S, Singh R, Rider RA, Chakraborty H, Dexter PR, Johnson JA, Skaar TC, Cavallari LH, et al. Genotype-guided antidepressant prescribing for patients with depression: a randomized clinical trial. JAMA Netw Open. 2026;9:(5):e2610609. https://doi.org/10.1001/jamanetworkopen.2026.10609
  • Cole JL, Kodali LK, Osinski M. Workflow and clinical utility of multigene preemptive pharmacogenomic testing in the emergency department: a single cohort study. J Pharm Technol. 2026 Aug 3. [Epub ahead of print]. https://doi.org/10.1177/87551225261472403
  • Tibben BM, Hein DW, Whirl-Carrillo M, Gaedigk A, Eadon MT, Minchin RF, Boukouvala S, Santos AR, Donnelly RS, Agúndez JAG, Caudle KE. Clinical function assignment of NAT2 alleles by the Clinical Pharmacogenetics Implementation Consortium Pharmacogenetics Curation Expert Panel. Clin Pharmacol Ther. 2026 Jul 31. [Epub ahead of print]. https://doi.org/10.1002/cpt.70420
  • Karnes JH, Bao C, Liang S, et al. Variation in SNX29 and acute vasodilator response in pulmonary arterial hypertension. Circ Res. 2026;139(2):e327117. https://doi.org/10.1161/CIRCRESAHA.125.327117
  • Denton J, Watkins SA, Shirazi FM, Walter FG, Karnes JH, et al. Characterization of anemia following rattlesnake envenomation in Arizona: a retrospective observational study. Clin Toxicol. 2026;64(6):490-496. https://doi.org/10.1080/15563650.2026.2616423
  • Mansel CO, Ghisays V, Mahnken JD, Swerdlow RH, Reiman EM, Karnes JH, et al. Downward bias in the association between APOE and Alzheimer’s disease using prevalent and by-proxy disease sampling in the All of Us research program. BMC Med Genomics. 2026;19(1):84. https://doi.org/10.1186/s12920-026-02362-1
  • Massmann A, Baye JF, Weaver M. Developing a statistical modeling-based machine learning approach for capturing drug dosing using a proton pump inhibitor case. Pharmacotherapy. 2026;46(2):e70083. https://doi.org/10.1002/phar.70083
  • Meissner BR, Younes F, Massmann A, Weaver M, Petry NJ. Aripiprazole and CYP2D6: a retrospective cohort study evaluating the impact of phenotype on metabolic abnormalities. Am J Health Syst Pharm. 2026;83(suppl 4):S2976-S2983. https://doi.org/10.1093/ajhp/zxaf345
  • Jacobsen K, Petry NJ, Weaver M, Weeder E, Massmann A. Clinician satisfaction with pharmacogenomics clinical services at a multistate health system. Clin Transl Sci. 2026;19(3):e70520. https://doi.org/10.1111/cts.70520
  • Nahid NA, Petry NJ, Baye JF, Gray CF, Myers RA, Elwood EN, Harris EC, Chakraborty H, Volpi S, Rider R, Dexter PR, Peterson JF, Skaar TC, Parvataneni HK, Cavallari LH, et al. Hydrocodone vs oxycodone and postoperative pain and opioid use in joint arthroplasty. JAMA Netw Open. 2026;9(7):e2623079. https://doi.org/10.1001/jamanetworkopen.2026.23079
  • Popejoy AB, Cragun D, Roberts MC, Bendz LM, Gonzales S, Haga SB, Wu RR, Petry NJ, et al. Factors facilitating adoption of pharmacogenetic testing by prescribers of antidepressants in four US health systems: a multi-site cross-sectional PGx implementation science study. J Pers Med. 2026;16(8):411. https://doi.org/10.3390/jpm16080411
  • Weaver M, Petry NJ, Cauwels J, Lupu RA, Massmann A. Prompt engineering of large language models for medication dose calculation. Clin Pharmacol Ther. 2026 Aug 9. [Epub ahead of print]. https://doi.org/10.1002/cpt.70421
  • Schultz A, Gregornik DB, Nguyen JQ. Sanford Children’s Genomic Medicine Consortium shows interinstitutional progression of pediatric pharmacogenomic programs, JAPhA Pract Innov. 2026;3(4):100120. https://doi.org/10.1016/j.japhpi.2026.100120
  • Stone RM, Hoffecker G, Schultz A, Davis BH, Bargal SA, Beitelshees AL, El Rouby N, Norris M, Rodriguez KJ, Limdi N, Cavallari LH, et al. CYP2C19 genotyping to guide clopidogrel prescribing for neurovascular indications: a survey of institutional approaches. Clin Pharmacol Ther. 2026 Jul 30. [Epub ahead of print]. https://doi.org/10.1002/cpt.70402
  • Tuteja S, Hicks JK, Cavallari LH, El Rouby N, Smith DM, et al. Leveraging implementation science to enhance the adoption of DPYD testing. Pharmacogenet. Genomics. 2026;36(2):80-82. https://doi.org/10.1097/FPC.0000000000000581
  • Zhang L, Lee AM, Maxim ZL, Munirathinam M, Larsen BS, Georgieff MK, Keedy KK, Reilly JL, Sweeney JA, Tran PV, Bishop JR. Brain-derived extracellular vesicles (BDEV) and BDEV protein associations with clinical phenotypes and treatment response in untreated first-episode psychosis. Brain Behav Immun. 2026 Jul 12. [Epub ahead of print]. https://doi.org/10.1016/j.bbi.2026.106912
  • Zhang L, Tholkes AJ, Cullen KR, Gunlicks-Stoessel ML, Mroz P, Farley JF, Johnson SG, Bishop JR. Who receives psychiatry-focused pharmacogenomic testing, and is it associated with prescribing patterns and acute care utilization in depression? Real-world evidence from a large health system. EBioMedicine. 2026;128:106275. https://doi.org/10.1016/j.ebiom.2026.106245

New ACCP Fellows

  • Aniwaa Owusu Obeng
  • Amy L. Pasternak
  • Natasha J. Petry
  • D. Max Smith

Other Notable Achievements

  • Lusi Zhang: Started a tenure-track Assistant Professor position with the Division of Translational and Clinical Pharmacology at Cincinnati Children’s Hospital Medical Center, alongside an affiliated faculty appointment at the University of Cincinnati College of Medicine.

Pulmonary PRN

Promotions

  • Megan E. Fleischman: Associate Professor, Concordia University Wisconsin School of Pharmacy, Mequon, WI.

Awards

  • Paul Boylan: Provost’s Teaching Award for Early Career Faculty, University of Oklahoma.

Publications

  • Boylan PM. K-type questions and the MPJE: recommendations for evidence-based item reform. Curr Pharm Teach Learn. 2026;18(10):102672. https://doi.org/10.1016/j.cptl.2026.102672
  • Lipari M. Pulmonary disorders. In: ACCP/ASHP 2026 Ambulatory Care Pharmacy Preparatory Review and Recertification Course. American College of Clinical Pharmacy; 2026:655-715.
  • Lipari M, Garwood CL, Berlie H, et al. Clinician perceptions of therapeutic inertia in type 2 diabetes mellitus: a qualitative study. J Am Coll Clin Pharm. 2026;9(2):e70146. https://doi.org/10.1002/jac5.70146
  • Ammar A, Sorochak N, Paxton R, Lipari M, et al. Long-acting insulin and hypoglycemia in critically ill patients with diabetes: a sensitivity analysis. J Intensive Care Med. 2026 Jul 6. [Epub ahead of print]. https://doi.org/10.1177/08850666261462876
  • Carris NW, Evoy K, Hughes J, Philbrick A, Singh-Franco D, Lipari M. Comment on “Adopting race-free estimated glomerular filtration rate for unifying medication-related decision-making: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy.” J Am Coll Clin Pharm. 2026;9(4):e70204. https://doi.org/10.1002/jac5.70204
  • Dacon C, Kale-Pradhan P, Lipari M. Assessing the impact of glucagon-like peptide-1 and glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor agonist shortages on glycemic control: a single center study. J Pharm Pract. 2026 May 5. [Epub ahead of print]. https://doi.org/10.1177/08971900261449175
  • Lobkovich A, Ferrari H, Martirosov AL, Mohammad I, Berlie H, Garwood C, Lipari M. Aspirin deprescribing interventions for primary prevention: a systematic review. Pharmacotherapy. 2026;46(3):e70121. https://doi.org/10.1002/phar.70121
  • Penny B, Lipari M, Gutenschwager D, et al. Assessment of comprehensive medication management incorporating a patient-completed medical and medication history form in community practice. J Am Pharm Assoc (2003). 2026;66(5):103476.
  • Fava J, Stephan E, Tansmore J, Sheikh S, Eisner M, Novak KJ. Impact of elexacaftor/tezacaftor/ivacaftor on systemic antibiotic utilization in pediatric patients with cystic fibrosis. Pediatric Pulmonol. 2026;61(8):e71749. https://doi.org/10.1002/ppul.71749

Presentations

  • Megan E. Fleischman:
    • Severe asthma. Presented at: Recorded on-demand CE module for ASHP Specialty Pharmacy Certificate Program—Advanced Pulmonary Disease States; March 2026; virtual.
    • COPD from alpha-1 antitrypsin deficiency. Presented at: Recorded on-demand CE module for ASHP Specialty Pharmacy Certificate Program—Advanced Pulmonary Disease States; March 2026; virtual.
    • Multisite analysis of health system specialty pharmacy interventions that lead to cost avoidance. Poster presented at: ASHP Pharmacy Futures Conference; June 15, 2026; St. Louis, MO.
    • Optimization of virtual patient outreach in the specialty pharmacy setting. Poster presented at: MCW Poster Event; 2026; Milwaukee, WI.
  • Melissa Lipari: Pulmonary disorders. Presented at: 2026 ACCP/ASHP Ambulatory Care Pharmacy Preparatory Review and Recertification Course; 2026; virtual.

Other Notable Achievements

  • Paul Boylan: Completed MS degree in Clinical and Translational Science, University of Oklahoma.

Transplant PRN

Publications

  • Arzate M, Nailor MD, Tokman S, Bay C, Madrid K, Goodlet KJ. Characteristics and clinical outcomes of postoperative pleural space infections among lung transplant recipients. Transpl Infect Dis. 2026;28(3):e70200. https://doi.org/10.1111/tid.70200
  • O’Connell MB, Prescott GM, Allen M, Connor SE, Ford E, Formea CM, Gibson CM, Goodlet KJ, et al. From awareness to action: increasing health equity by addressing cultural and structural barriers in pharmacy practice, education, and research. J Am Coll Clin Pharm. 2026;9(4):e70206. https://doi.org/10.1002/jac5.70206
  • Blocker S, Henry M, Leick M. Low statin use post-liver transplant despite increased rates of dyslipidemia. J Pharm Pract. 2026 Jul 13. [Epub ahead of print]. https://doi.org/10.1177/08971900261469304
  • Pierce D, Brokhof M, Fredrick S, Kelly B, Sawyer M, Summers B, Tchen S, Walter K, Szempruch K. Comment on “Adopting race-free estimated glomerular filtration rate for unifying medication-related decision-making: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy.” J Am Coll Clin Pharm. 2026;9(4):e70201. https://doi.org/10.1002/jac5.70201
  • Eldabbas H, Harward LA, Abdelmessih E, Bell M, Christ L, Trofe J. Retrospective program evaluation of oral dextrose gel in preventing intensive care nursery admissions for neonatal hypoglycemia. J Pediatr Pharmacol Ther. [In press]
  • Hussain SM, Malat G, Tandukar S, Trofe J, et al. Tolerability and effectiveness of tirzepatide in kidney transplant recipients: real world experience from a single center study. Transplantation. 2026;110(7):e1549-e1550. https://doi.org/10.1097/TP.0000000000005711
  • Ilia C, Walshe C, Nguyen L, Sammons C, Norris M, Forte A, Trofe J, et al. Cost-savings realized using rabbit anti-thymocyte globulin ideal body weight dosing for kidney transplantation induction immunosuppression. Prog Transplant. 2026;36(2):74-80. https://doi.org/10.1177/15269248261456512
  • Leonberg-Yoo A, Leonberg KE, Abu Gazala S, Hryzak S, Redfield RR, Parsons RF, Agarwal AK, Delgado MK, Lee D, Trofe J. Patient-reported opioid use and pain management after living kidney donation. Transplant Direct. 2026;12(6):e1954. https://doi.org/10.1097/TXD.0000000000001954
  • Sane R, Nguyen L, Tandukar S, Malat G, Walshe C, Galle M, Biro C, Benjamin S, Joy K, Trofe J. Pharmacy resident performed longitudinal medication adherence assessments in candidates for deceased donor kidney transplant. Prog Transplant. 2026;36(3):109-115. https://doi.org/10.1177/15269248261469213
  • Flynn K, Hixson H, Aitken S, Hagopian J, Chan K, Lyu D, Belloli B, Combs M, Walter K. Crushed posaconazole delayed-release tablets have reduced bioavailability and interaction with tacrolimus relative to other administration routes. Ann Pharmacother. 2026 May 4. [Epub ahead of print]. https://doi.org/10.1177/10600280261434694

Presentations

  • Kellie Goodlet:
    • Diagnostic utility of Mucor PCR in lung transplant recipients: a retrospective analysis of 3,588 bronchoalveolar lavage samples. Poster presented at: ISHLT 46th Annual Meeting and Scientific Sessions; April 2026; Toronto, Ontario, Canada.
    • BK polyomavirus infection in lung transplant recipients with renal insufficiency: does underlying lung disease influence post-transplant risk? Poster presented at: American Thoracic Society International Conference; May 2026; Orlando, FL.
  • Edward Horn: Antimicrobial dosing in difficult populations across organ support systems—focus on ECMO and RRT modalities. Presented at: ISHLT Academy – ID/Pharmacy. ISHLT Annual Meeting 2026; April 2026; Toronto, Ontario, Canada.
  • Mary Leick:
    • Transplant pharmacy intervention to address nonadherence. Presented at: American Transplant Congress 2026; June 2026; Boston, MA.
    • Phosphorus supplementation in living liver transplant donors. Presented at: 2026 ACCP Virtual Poster Symposium; May 2026; virtual.
    • The effect of vitamin C deficiency on clinical outcomes in liver transplant recipients. Presented at: 2026 ACCP Virtual Poster Symposium; May 2026; virtual.
    • Early invasive fungal infections in adult liver transplant patients. Presented at: American Transplant Congress 2026; June 2026; Boston, MA.
    • Exploring the correlation between frailty scores, vitamin deficiencies, and malnutrition in adult liver transplant recipients. Presented at: American Transplant Congress 2026; June 2026; Boston, MA.
    • Universal prophylaxis versus preemptive therapy for the management of cytomegalovirus infection in adult liver transplant recipients. Presented at: American Transplant Congress 2026; June 2026; Boston, MA.
  • Kristen Szempruch:
    • The development of a standardized approach at time of transplant to improve care after bariatric surgery. Poster presented at: American Transplant Congress Annual Conference 2026; June 2026; Boston, MA.
    • Three-year follow-up comparing anti-thymocyte globulin vs alemtuzumab induction with a steroid free maintenance regimen. Platform presentation at: American Transplant Congress 2026 Annual Conference; June 2026; Boston, MA.
  • Jennifer Trofe: Cognitive functioning in transplant: best practices for assessment and intervention across the transplant trajectory, session: risk and protective factors for CNI neurotoxicity. Presented at: 2026 American Transplant Congress; June 2026; Boston, MA.

Other Notable Achievements

  • Ashley Feist: Appointed as a fellow of the American Society of Transplantation (FAST).
  • Kellie Goodlet: Appointed as a fellow of the Infectious Diseases Society of America (FIDSA).
  • Edward Horn: Appointed as a fellow of the International Society of Heart and Lung Transplantation.
  • Dana Pierce: Appointed as a fellow of the American Society of Transplantation (FAST).
  • Kristen Szempruch: Appointed as a fellow of the American Society of Transplantation (FAST).
  • Shirley Tsunoda: Appointed as a fellow of the American Society of Transplantation (FAST).

Women’s Health PRN

Promotions

  • Nicole Campbell: Clinical Associate Professor of Pharmacy Practice, Fairleigh Dickinson University SoPHS.

Publications

  • Brandon H, Morgan RJ, Cain J, et al. A scoping review of pharmacy trainee perceptions of research and scholarship. Curr Pharm Teach Learn. 2026;18(11):102721. https://doi.org/10.1016/j.cptl.2026.102721
  • Brandon H, Scarduzio JA, Riaz A, et al. A qualitative analysis of pharmacy educator and recent graduates’ perceptions regarding declining NAPLEX first-time pass rates. Curr Pharm Teach Learn. 2026;18(8):102660. https://doi.org/10.1016/j.cptl.2026.102660
  • Eldabbas H, Harward LA, Abdelmessih E, et al. Retrospective program evaluation of oral dextrose gel in preventing intensive care nursery admissions for neonatal hypoglycemia. J Pediatr Pharmacol Ther. [In press]
  • Kirschen GW, Eldabbas H, Nichols T, et al. Concentrated magnesium sulfate and pharmacokinetics-guided neuroprotection in pregnant patients with cardiac disease. J Clin Pharmacol. 2026;66(8):e70254. https://doi.org/10.1002/jcph.70254
  • Finks SW. Dyslipidemia. In: Franks A, Marrs J, Parker RB, et al, eds. The APhA Complete Review for Pharmacy. 14th ed. American Pharmacists Association; June 2026:chap 16. https://doi.org/10.21019/9781582123875.ch16
  • Finks SW. Update on the 2025 American College of Cardiology/American Heart Association (ACC/AHA) Multi-Society Hypertension Guideline. Pharmacotherapy: Principles and Practice. PPP Updates. McGraw-Hill Companies; 2025. https://ppp.mhmedical.com/updatesContent.aspx?gbosid=665932
  • Finks SW, Cieri-Hutcherson NE, Vernon V, McBane SE. Menopausal hormone therapy: a narrative review of contemporary evidence. Pharmacotherapy. 2026;46(7):e70178. https://doi.org/10.1002/phar.70178
  • DiDomenico RJ, Dobesh PP, Finks SW. Acute coronary syndrome. In: DiPiro JT, Yee GC, Posey LM, et al, eds. Pharmacotherapy: A Pathophysiologic Approach. 13th ed. McGraw Hill; 2026:chap 37.
  • McFarland MS, Finks SW, Zagel A, et al. Building the practice foundations to deliver comprehensive medication management. J Am Coll Clin Pharm. 2026;9(5):e70218. https://doi.org/10.1002/jac5.70218

Presentations

  • Hope Brandon:
    • From pre-conception to post-menopause: updates in women’s health. Presented at: UTHSC CE series; February, March, and April 2026; virtual and Nashville, TN.
    • Transforming pharmacy education with AI: an interactive workshop for pharmacy educators. Presented at: Nashville Area Pharmacist Association; January 2026; Nashville, TN.
  • Shannon Willhite Finks:
    • Menopause 101. Presented online with live question and answer session for FreeCE.com webinar series. June 15, 2026, and July 15, 2026; virtual.
    • VanDuzee T, Finks SW. Interdisciplinary knowledge and perceptions of pharmacist involvement in supplement use for menopausal care. Abstract 1590. Presented at: ACCP 2026 Virtual Poster Symposium; May 20, 2026; virtual.
    • Verret LM, Finks SW. Supraphysiologic testosterone concentrations and androgenic adverse effects after subcutaneous testosterone pellet therapy in menopausal women: a retrospective case series. Abstract 1582. Presented at: ACCP 2026 Virtual Poster Symposium; May 20, 2026; virtual.
Dedicated to Excellence in Clinical Pharmacy Practice, Research, and Education
© American College of Clinical Pharmacy
World Headquarters
13000 W 87th St. Pkwy
Lenexa, KS 66215-4530
(913) 492-3311
www.accp.com
Washington Office
1455 Pennsylvania Ave., NW
Suite 400
Washington, DC 20004-1017
(202) 621-1820
Other Links
Related Sites